{"section":{"filename":"s2001.html","chapter":"2000","section_number":"2001","title":"Duty of Disclosure, Candor, and Good Faith","revision_tag":"R-08.2017","bytes":87714,"sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb","subsection_count":11,"max_depth":2,"subsections":[{"number":"2001.01","title":"Who Has Duty To Disclose","revision_tag":"R-07.2022","depth":1},{"number":"2001.02","title":"[Reserved]","revision_tag":null,"depth":1},{"number":"2001.03","title":"To Whom Duty of Disclosure Is Owed","revision_tag":"R-08.2017","depth":1},{"number":"2001.04","title":"Information Under 37 CFR 1.56(a)","revision_tag":"R-07.2022","depth":1},{"number":"2001.05","title":"Materiality Under 37 CFR 1.56(b)","revision_tag":"R-07.2022","depth":1},{"number":"2001.06","title":"Sources of Information under 37 CFR 1.56","revision_tag":"R-07.2022","depth":1},{"number":"2001.06(a)","title":"Prior Art Cited in Related Foreign Applications","revision_tag":"R-08.2012","depth":2},{"number":"2001.06(b)","title":"Information Relating to or From Copending United States Patent Applications","revision_tag":"R-08.2017","depth":2},{"number":"2001.06(c)","title":"Information From Related Litigation and/or Trial Proceedings","revision_tag":"R-08.2017","depth":2},{"number":"2001.06(d)","title":"Information Relating to Claims Copied From a Patent","revision_tag":"R-08.2017","depth":2},{"number":"2001.06(e)","title":"Information Relating to Regulatory Review","revision_tag":"R-07.2022","depth":2}]},"quality":"structured","cited_authorities":{"file_section":"2001","cases":[{"key":"case:542f.supp.933","slug":"gemveto-jewelry-co-v-lambert-bros-inc","short_name":"Gemveto Jewelry Co. v. Lambert Bros., Inc.","canonical_citation":"Gemveto Jewelry Co. v. Lambert Bros., Inc., 542 F. Supp. 933, 216 USPQ 976 (S.D.N.Y. 1982)","decision_year":1982,"court":"S.D.N.Y.","holding_summary":"A patent may be held invalid or unenforceable where the patentee's foreign counsel failed to disclose to U.S. counsel or the Office material prior art cited by a foreign patent office in a corresponding foreign application; the duty of candor extends to such information.","holding_confidence":"high","mentions":2,"propositions":[]},{"key":"case:466f.2d767","slug":"armour-co-v-swift-co","short_name":"Armour & Co. v. Swift & Co.","canonical_citation":"Armour & Co. v. Swift & Co., 466 F.2d 767, 175 USPQ 70 (7th Cir. 1972)","decision_year":1972,"court":"7th Cir.","holding_summary":"It is unfair to assume a busy examiner retains details of every pending file when reviewing an application; the applicant bears the burden of presenting the examiner with a complete and accurate record, including identifying copending applications with similar subject matter material to patentability.","holding_confidence":"high","mentions":2,"propositions":[]},{"key":"case:329f.3d1358","slug":"dayco-prod-inc-v-total-containment-inc","short_name":"Dayco Prod., Inc. v. Total Containment, Inc.","canonical_citation":"Dayco Prod., Inc. v. Total Containment, Inc., 329 F.3d 1358, 66 USPQ2d 1801 (Fed. Cir. 2003)","decision_year":2003,"court":"Fed. Cir.","holding_summary":"A contrary decision of another examiner reviewing substantially similar claims is material to patentability, and a copending application may be material even when it cannot shorten patent term; applicants must bring such related applications to each examiner's attention.","holding_confidence":"high","mentions":2,"propositions":[]},{"key":"case:267f.3d1370","slug":"brasseler-u-s-a-i-l-p-v-stryker-sales-corp","short_name":"Brasseler, U.S.A. I, L.P. v. Stryker Sales Corp","canonical_citation":"Brasseler, U.S.A. I, L.P. v. Stryker Sales Corp., 267 F.3d 1370, 60 USPQ2d 1482 (Fed. Cir. 2001)","decision_year":2001,"court":"Fed. Cir.","holding_summary":"Once an attorney or applicant has notice that apparently material information exists, that person cannot ignore the notice to avoid the duty to disclose.","holding_confidence":"high","mentions":1,"propositions":[]},{"key":"case:144f.supp.3d530","slug":"regeneron-pharm-inc-v-merus-b-v","short_name":"Regeneron Pharm., Inc. v. Merus B.V.","canonical_citation":"Regeneron Pharm., Inc. v. Merus B.V., 144 F. Supp. 3d 530 (S.D.N.Y. 2015)","decision_year":2015,"court":"S.D.N.Y.","holding_summary":"Individuals subject to the duty of disclosure cannot assume the examiner is aware of other applications material to patentability and must instead bring such co-pending applications to the examiner's attention.","holding_confidence":"high","mentions":1,"propositions":[]},{"key":"case:43uspq2d1288","slug":"environ-prods-inc-v-total-containment-inc","short_name":"Environ Prods., Inc. v. Total Containment, Inc.","canonical_citation":"Environ Prods., Inc. v. Total Containment, Inc., 43 USPQ2d 1288 (E.D. Pa. 1997)","decision_year":1997,"court":"E.D. Pa.","holding_summary":"Assertions made during litigation that contradict assertions made to the examiner are material information that must be brought to the Office's attention.","holding_confidence":"high","mentions":1,"propositions":[]},{"key":"case:120f.3d1253","slug":"critikon-inc-v-becton-dickinson-vascular-access-inc","short_name":"Critikon, Inc. v. Becton Dickinson Vascular Access, Inc.","canonical_citation":"Critikon, Inc. v. Becton Dickinson Vascular Access, Inc., 120 F.3d 1253, 43 USPQ2d 1666 (Fed. Cir. 1997)","decision_year":1997,"court":"Fed. Cir.","holding_summary":"A patent may be held unenforceable for inequitable conduct based on the patentee's failure to disclose a relevant reference and failure to disclose ongoing litigation to the Office.","holding_confidence":"high","mentions":1,"propositions":["patent held unenforceable due to inequitable conduct based on patentee's failure to disclose a relevant reference and for failing to disclose ongoing litigation"]},{"key":"case:11f.4th1345","slug":"belcher-pharmaceuticals-llc-v-hospira-inc","short_name":"Belcher Pharmaceuticals, LLC v. Hospira, Inc.","canonical_citation":"Belcher Pharmaceuticals, LLC v. Hospira, Inc., 11 F.4th 1345, 2021 USPQ2d 909 (Fed. Cir. 2021)","decision_year":2021,"court":"Fed. Cir.","holding_summary":"Statements made to other government agencies such as the FDA must be consistent with positions taken before the USPTO; withholding FDA submissions about prior art that contradicted prosecution positions supported a determination of inequitable conduct.","holding_confidence":"high","mentions":1,"propositions":[]},{"key":"case:proceedingno.d2021-14","slug":"in-re-hao","short_name":"In re Hao","canonical_citation":"In re Hao, Proceeding No. D2021-14 (USPTO Apr. 27, 2022)","decision_year":2022,"court":"USPTO","holding_summary":"Non-compliance with the certification requirements of 37 CFR 11.18 in papers submitted to the USPTO can support disciplinary sanctions against a practitioner.","holding_confidence":"high","mentions":1,"propositions":["involving disciplinary sanctions predicated on non-compliance with 37 CFR 11.18"]},{"key":"case:proceedingno.d2013-17","slug":"in-re-tendler","short_name":"In re Tendler","canonical_citation":"In re Tendler, Proceeding No. D2013-17 (USPTO Jan. 1, 2014)","decision_year":2014,"court":"USPTO","holding_summary":"A practitioner who learns of inaccuracies in a declaration filed with the USPTO must promptly correct the written record; failure to do so warranted a four-year suspension.","holding_confidence":"high","mentions":1,"propositions":["suspending a practitioner for four years for failure to correct the written record after learning of inaccuracies in a declaration the practitioner had filed"]},{"key":"case:326f.3d1226","slug":"bristol-myers-squibb-co-v-rhone-poulenc-rorer-inc","short_name":"Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc.","canonical_citation":"Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc., 326 F.3d 1226, 66 USPQ2d 1481 (Fed. Cir. 2003)","decision_year":2003,"court":"Fed. Cir.","holding_summary":"Materiality under the duty of disclosure is not limited to prior art; it embraces any information a reasonable examiner would be substantially likely to consider important in deciding whether to allow an application, including a non-prior-art article material to enablement.","holding_confidence":"high","mentions":1,"propositions":["finding article which was not prior art to be material to enablement issue"]}],"statutes":[{"key":"us_cfr:37:1.56","slug":"37-cfr-1-56","canonical_citation":"37 CFR 1.56","mentions":30},{"key":"us_cfr:37:1.555","slug":"37-cfr-1-555","canonical_citation":"37 CFR 1.555","mentions":5},{"key":"us_cfr:37:1.313","slug":"37-cfr-1-313","canonical_citation":"37 CFR 1.313","mentions":4},{"key":"us_cfr:37:11.18","slug":"37-cfr-11-18","canonical_citation":"37 CFR 11.18","mentions":3},{"key":"us_cfr:37:1.501","slug":"37-cfr-1-501","canonical_citation":"37 CFR 1.501","mentions":2},{"key":"us_cfr:37:1.291","slug":"37-cfr-1-291","canonical_citation":"37 CFR 1.291","mentions":2},{"key":"us_cfr:37:1.105","slug":"37-cfr-1-105","canonical_citation":"37 CFR 1.105","mentions":2},{"key":"us_cfr:37:1.97","slug":"37-cfr-1-97","canonical_citation":"37 CFR 1.97","mentions":2},{"key":"us_cfr:37:41.202","slug":"37-cfr-41-202","canonical_citation":"37 CFR 41.202","mentions":2},{"key":"us_cfr:37:1.290","slug":"37-cfr-1-290","canonical_citation":"37 CFR 1.290","mentions":1},{"key":"us_cfr:37:1.114","slug":"37-cfr-1-114","canonical_citation":"37 CFR 1.114","mentions":1},{"key":"us_cfr:37:1.98","slug":"37-cfr-1-98","canonical_citation":"37 CFR 1.98","mentions":1},{"key":"us_usc:35:257","slug":"35-usc-257","canonical_citation":"35 U.S.C. 257","mentions":1},{"key":"us_cfr:37:1.625","slug":"37-cfr-1-625","canonical_citation":"37 CFR 1.625","mentions":1}],"cross_references":[{"key":"mpep:609","section_number":"609","title":"Information Disclosure Statement","exists":true,"mentions":3},{"key":"mpep:704","section_number":"704","title":"Search and Requirements for Information","exists":true,"mentions":1},{"key":"mpep:706","section_number":"706","title":"Rejection of Claims","exists":true,"mentions":1},{"key":"mpep:719","section_number":"719","title":"File Wrapper","exists":true,"mentions":1},{"key":"mpep:1308","section_number":"1308","title":"Withdrawal From Issue","exists":true,"mentions":1},{"key":"mpep:1442","section_number":"1442","title":"Special Status","exists":true,"mentions":1},{"key":"mpep:1901","section_number":"1901","title":"Protest Under 37 CFR 1.291","exists":true,"mentions":1},{"key":"mpep:2004","section_number":"2004","title":"Aids to Compliance With Duty of Disclosure","exists":true,"mentions":1},{"key":"mpep:2015","section_number":"2015","title":"Duties of Disclosure and Reasonable Inquiry Arise in Dealings With Other Government Agencies","exists":true,"mentions":2},{"key":"mpep:2016","section_number":"2016","title":"Fraud, Inequitable Conduct, or Violation of Duty of Disclosure Affects All Claims","exists":true,"mentions":1},{"key":"mpep:2164","section_number":"2164","title":"The Enablement Requirement","exists":true,"mentions":1},{"key":"mpep:2242","section_number":"2242","title":"Criteria for Deciding Request Filed under 35 U.S.C. 302","exists":true,"mentions":1},{"key":"mpep:2258","section_number":"2258","title":"Scope of Ex Parte Reexamination","exists":true,"mentions":1},{"key":"mpep:2280","section_number":"2280","title":"Information Material to Patentability in Reexamination Proceeding Filed under 35 U.S.C. 302","exists":true,"mentions":1},{"key":"mpep:2684","section_number":"2684","title":"Information Material to Patentability in Reexamination Proceeding","exists":true,"mentions":1},{"key":"mpep:2820","section_number":"2820","title":"Submission of Notification of Other Prior or Concurrent Post-Patent Office Proceedings","exists":true,"mentions":1}],"form_paragraphs":[]},"structured_data":{"nodes":[{"id":"se_dyefh5xi","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_dyefh5xi","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195453","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001","section_number":"2001","chapter":"2000","depth":0,"title":"Duty of Disclosure, Candor, and Good Faith","revision_tag":"R-08.2017","children_ids":["sb_bfckhcyf","pb_f4337w7h","sb_bosalugb","pb_crqyzva3","pb_nww7tmrh","pb_lciirwhl","se_5hb4c2hn","se_ozog5fuk","se_bsmwel2l","se_cuxefq5m","se_rlnwhhop","se_mos7nx7f"]},{"id":"se_5hb4c2hn","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_5hb4c2hn","effective_range":{"start_revision":"R-07.2022","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195539","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_01","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_01","section_number":"2001.01","chapter":"2000","depth":1,"title":"Who Has Duty To Disclose","revision_tag":"R-07.2022","parent_section_id":"se_dyefh5xi","children_ids":["sb_z6zsj7ds","pb_robgy4nm","pb_saroijsf","sb_tzy6o6na","pb_2oa3pizx","pb_akjpooxh","pb_hnhcsilf","pb_g25sgdio"]},{"id":"se_ozog5fuk","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_ozog5fuk","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_d22347_29dee_13d","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_02","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_02","section_number":"2001.02","chapter":"2000","depth":1,"title":"[Reserved]","parent_section_id":"se_dyefh5xi","children_ids":["pb_izxqdjbj"]},{"id":"se_bsmwel2l","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_bsmwel2l","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195574","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_03","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_03","section_number":"2001.03","chapter":"2000","depth":1,"title":"To Whom Duty of Disclosure Is Owed","revision_tag":"R-08.2017","parent_section_id":"se_dyefh5xi","children_ids":["pb_vzxdktxo"]},{"id":"se_cuxefq5m","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_cuxefq5m","effective_range":{"start_revision":"R-07.2022","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195585","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_04","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_04","section_number":"2001.04","chapter":"2000","depth":1,"title":"Information Under 37 CFR 1.56(a)","revision_tag":"R-07.2022","parent_section_id":"se_dyefh5xi","children_ids":["sb_t3mgsvbt","pb_q5b2lacb","pb_5fkbbah4","pb_42ureqy5","pb_uh4v4dgv","pb_t5drfrlx","pb_wltefpvy","pb_vvpsvooy","pb_shn7jew4","pb_otisysyv","pb_mj3amqhn","pb_lm6z5iv4","ls_hsxdcjka","pb_5tavpib3","pb_gyopr5lp","pb_raw3c6uh","pb_mymzesyu"]},{"id":"se_rlnwhhop","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_rlnwhhop","effective_range":{"start_revision":"R-07.2022","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195810","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_05","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_05","section_number":"2001.05","chapter":"2000","depth":1,"title":"Materiality Under 37 CFR 1.56(b)","revision_tag":"R-07.2022","parent_section_id":"se_dyefh5xi","children_ids":["sb_tysaiziu","pb_yqwjusoz","pb_vvga4maw","pb_usppjpte","pb_vgvxkuf7"]},{"id":"se_mos7nx7f","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_mos7nx7f","effective_range":{"start_revision":"R-07.2022","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195865","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06","section_number":"2001.06","chapter":"2000","depth":1,"title":"Sources of Information under 37 CFR 1.56","revision_tag":"R-07.2022","parent_section_id":"se_dyefh5xi","children_ids":["pb_mawk3sgk","pb_iegaczlf","se_pun5vtgq","se_4mzlcy7f","se_jeakewet","se_mqkgz2vr","se_dw4peeun"]},{"id":"se_pun5vtgq","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_pun5vtgq","effective_range":{"start_revision":"R-08.2012","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195900","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06_a","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06_a","section_number":"2001.06(a)","chapter":"2000","depth":2,"title":"Prior Art Cited in Related Foreign Applications","revision_tag":"R-08.2012","parent_section_id":"se_mos7nx7f","children_ids":["pb_necvee6x","nq_6qsfxz2j"]},{"id":"se_4mzlcy7f","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_4mzlcy7f","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195923","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06_b","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06_b","section_number":"2001.06(b)","chapter":"2000","depth":2,"title":"Information Relating to or From Copending United States Patent Applications","revision_tag":"R-08.2017","parent_section_id":"se_mos7nx7f","children_ids":["pb_3bejxofa","nq_uax4hxhp","pb_n2thwjwr","pb_tpvgz6f3","pb_bli7rsgm"]},{"id":"se_jeakewet","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_jeakewet","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195990","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06_c","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06_c","section_number":"2001.06(c)","chapter":"2000","depth":2,"title":"Information From Related Litigation and/or Trial Proceedings","revision_tag":"R-08.2017","parent_section_id":"se_mos7nx7f","children_ids":["pb_yziethnb","pb_rrgoy4mp","pb_kj6y7dzb","pb_bjsng7pm"]},{"id":"se_mqkgz2vr","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_mqkgz2vr","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e196020","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06_d","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06_d","section_number":"2001.06(d)","chapter":"2000","depth":2,"title":"Information Relating to Claims Copied From a Patent","revision_tag":"R-08.2017","parent_section_id":"se_mos7nx7f","children_ids":["pb_glhty7ys"]},{"id":"se_dw4peeun","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_dw4peeun","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_d337d9_22eba_22e","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06_e","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2001_06_e","section_number":"2001.06(e)","chapter":"2000","depth":2,"title":"Information Relating to Regulatory Review","revision_tag":"R-07.2022","parent_section_id":"se_mos7nx7f","children_ids":["pb_3hhbvhrz","pb_peghdvd3"]},{"id":"ls_uxfb3h42","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_uxfb3h42","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195462","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"alpha_lower","nesting_depth":1,"host_section_id":"se_dyefh5xi","item_ids":["li_4h27wm4q","li_7pcl5dj2","li_e3a2tzzh","li_5cxqbexy","li_eqenbzjv"],"parent_list_item_id":null},{"id":"ls_arw3frva","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_arw3frva","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195472","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"arabic","nesting_depth":2,"host_section_id":"se_dyefh5xi","item_ids":["li_6h5ejwfi","li_iz4kmos4"],"parent_list_item_id":"li_4h27wm4q"},{"id":"li_6h5ejwfi","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_6h5ejwfi","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (1) Prior art cited in search reports of a foreign patent\n office in a counterpart application, and\n
    • ","rendered_text_plain":"(1) Prior art cited in search reports of a foreign patent office in a counterpart application, and","provenance":{"source_file":"s2001.html","source_anchor":"d0e195472","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(1)","enumerator_ordinal":0,"parent_list_id":"ls_arw3frva"},{"id":"li_iz4kmos4","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_iz4kmos4","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (2) The closest information over which individuals associated\n with the filing or prosecution of a patent application believe any pending\n claim patentably defines, to make sure that any material information\n contained therein is disclosed to the Office.\n
    • ","rendered_text_plain":"(2) The closest information over which individuals associated with the filing or prosecution of a patent application believe any pending claim patentably defines, to make sure that any material information contained therein is disclosed to the Office.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195476","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(2)","enumerator_ordinal":1,"parent_list_id":"ls_arw3frva"},{"id":"li_4h27wm4q","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_4h27wm4q","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"(a) A patent by its very nature is affected with a public interest.\n The public interest is best served, and the most effective patent examination\n occurs when, at the time an application is being examined, the Office is aware of\n and evaluates the teachings of all information material to patentability. Each\n individual associated with the filing and prosecution of a patent application has\n a duty of candor and good faith in dealing with the Office, which includes a duty\n to disclose to the Office all information known to that individual to be material\n to patentability as defined in this section. The duty to disclose information\n exists with respect to each pending claim until the claim is cancelled or\n withdrawn from consideration, or the application becomes abandoned. Information\n material to the patentability of a claim that is cancelled or withdrawn from\n consideration need not be submitted if the information is not material to the\n patentability of any claim remaining under consideration in the application. There\n is no duty to submit information which is not material to the patentability of any\n existing claim. The duty to disclose all information known to be material to\n patentability is deemed to be satisfied if all information known to be material to\n patentability of any claim issued in a patent was cited by the Office or submitted\n to the Office in the manner prescribed by §§ 1.97(b)-(d) and\n 1.98. However, no patent will be granted on an application\n in connection with which fraud on the Office was practiced or attempted or the\n duty of disclosure was violated through bad faith or intentional misconduct. The\n Office encourages applicants to carefully examine:\n ","rendered_text_plain":"(a) A patent by its very nature is affected with a public interest. The public interest is best served, and the most effective patent examination occurs when, at the time an application is being examined, the Office is aware of and evaluates the teachings of all information material to patentability. Each individual associated with the filing and prosecution of a patent application has a duty of candor and good faith in dealing with the Office, which includes a duty to disclose to the Office all information known to that individual to be material to patentability as defined in this section. The duty to disclose information exists with respect to each pending claim until the claim is cancelled or withdrawn from consideration, or the application becomes abandoned. Information material to the patentability of a claim that is cancelled or withdrawn from consideration need not be submitted if the information is not material to the patentability of any claim remaining under consideration in the application. There is no duty to submit information which is not material to the patentability of any existing claim. The duty to disclose all information known to be material to patentability is deemed to be satisfied if all information known to be material to patentability of any claim issued in a patent was cited by the Office or submitted to the Office in the manner prescribed by §§ 1.97(b)-(d) and 1.98. However, no patent will be granted on an application in connection with which fraud on the Office was practiced or attempted or the duty of disclosure was violated through bad faith or intentional misconduct. The Office encourages applicants to carefully examine:","provenance":{"source_file":"s2001.html","source_anchor":"d0e195462","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(a)","enumerator_ordinal":0,"parent_list_id":"ls_uxfb3h42","child_ids":["ls_arw3frva"]},{"id":"ls_tc62mw6q","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_tc62mw6q","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195484","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"arabic","nesting_depth":2,"host_section_id":"se_dyefh5xi","item_ids":["li_ruo554bk","li_rvf4w5wg","li_ge73pwrn"],"parent_list_item_id":"li_7pcl5dj2"},{"id":"li_ruo554bk","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_ruo554bk","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (1) It establishes, by itself or in combination with other\n information, a prima facie case of unpatentability of a\n claim; or\n
    • ","rendered_text_plain":"(1) It establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or","provenance":{"source_file":"s2001.html","source_anchor":"d0e195484","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(1)","enumerator_ordinal":0,"parent_list_id":"ls_tc62mw6q"},{"id":"ls_igsgycar","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_igsgycar","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195495","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"roman_lower","nesting_depth":3,"host_section_id":"se_dyefh5xi","item_ids":["li_xty5mhnn","li_bbnzmgon"],"parent_list_item_id":"li_rvf4w5wg"},{"id":"li_xty5mhnn","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_xty5mhnn","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (i) Opposing an argument of unpatentability relied on by\n the Office, or\n
    • ","rendered_text_plain":"(i) Opposing an argument of unpatentability relied on by the Office, or","provenance":{"source_file":"s2001.html","source_anchor":"d0e195495","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(i)","enumerator_ordinal":0,"parent_list_id":"ls_igsgycar"},{"id":"li_bbnzmgon","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_bbnzmgon","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (ii) Asserting an argument of patentability.
    • ","rendered_text_plain":"(ii) Asserting an argument of patentability.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195499","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(ii)","enumerator_ordinal":1,"parent_list_id":"ls_igsgycar"},{"id":"li_rvf4w5wg","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_rvf4w5wg","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"(2) It refutes, or is inconsistent with, a position the\n applicant takes in:\n ","rendered_text_plain":"(2) It refutes, or is inconsistent with, a position the applicant takes in:","provenance":{"source_file":"s2001.html","source_anchor":"d0e195491","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(2)","enumerator_ordinal":1,"parent_list_id":"ls_tc62mw6q","child_ids":["ls_igsgycar"]},{"id":"li_ge73pwrn","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_ge73pwrn","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (3) A prima facie case of unpatentability is\n established when the information compels a conclusion that a claim is\n unpatentable under the preponderance of evidence, burden-of-proof standard,\n giving each term in the claim its broadest reasonable construction\n consistent with the specification, and before any consideration is given to\n evidence which may be submitted in an attempt to establish a contrary\n conclusion of patentability.\n
    • ","rendered_text_plain":"(3) A prima facie case of unpatentability is established when the information compels a conclusion that a claim is unpatentable under the preponderance of evidence, burden-of-proof standard, giving each term in the claim its broadest reasonable construction consistent with the specification, and before any consideration is given to evidence which may be submitted in an attempt to establish a contrary conclusion of patentability.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195503","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(3)","enumerator_ordinal":2,"parent_list_id":"ls_tc62mw6q"},{"id":"li_7pcl5dj2","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_7pcl5dj2","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"(b) Under this section, information is material to patentability when\n it is not cumulative to information already of record or being made of record in\n the application, and\n ","rendered_text_plain":"(b) Under this section, information is material to patentability when it is not cumulative to information already of record or being made of record in the application, and","provenance":{"source_file":"s2001.html","source_anchor":"d0e195480","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(b)","enumerator_ordinal":1,"parent_list_id":"ls_uxfb3h42","child_ids":["ls_tc62mw6q"]},{"id":"ls_ncfypzjz","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_ncfypzjz","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195514","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"arabic","nesting_depth":2,"host_section_id":"se_dyefh5xi","item_ids":["li_br7g2oye","li_oryw7abm","li_uwjsw7p4"],"parent_list_item_id":"li_e3a2tzzh"},{"id":"li_br7g2oye","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_br7g2oye","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (1) Each inventor named in the application;
    • ","rendered_text_plain":"(1) Each inventor named in the application;","provenance":{"source_file":"s2001.html","source_anchor":"d0e195514","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(1)","enumerator_ordinal":0,"parent_list_id":"ls_ncfypzjz"},{"id":"li_oryw7abm","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_oryw7abm","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (2) Each attorney or agent who prepares or prosecutes the\n application; and\n
    • ","rendered_text_plain":"(2) Each attorney or agent who prepares or prosecutes the application; and","provenance":{"source_file":"s2001.html","source_anchor":"d0e195518","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(2)","enumerator_ordinal":1,"parent_list_id":"ls_ncfypzjz"},{"id":"li_uwjsw7p4","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_uwjsw7p4","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (3) Every other person who is substantively involved in the\n preparation or prosecution of the application and who is associated with the\n inventor, the applicant, an assignee, or anyone to whom there is an\n obligation to assign the application. \n
    • ","rendered_text_plain":"(3) Every other person who is substantively involved in the preparation or prosecution of the application and who is associated with the inventor, the applicant, an assignee, or anyone to whom there is an obligation to assign the application.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195522","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(3)","enumerator_ordinal":2,"parent_list_id":"ls_ncfypzjz"},{"id":"li_e3a2tzzh","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_e3a2tzzh","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"(c) Individuals associated with the filing or prosecution of a patent\n application within the meaning of this section are:\n ","rendered_text_plain":"(c) Individuals associated with the filing or prosecution of a patent application within the meaning of this section are:","provenance":{"source_file":"s2001.html","source_anchor":"d0e195510","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(c)","enumerator_ordinal":2,"parent_list_id":"ls_uxfb3h42","child_ids":["ls_ncfypzjz"]},{"id":"li_5cxqbexy","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_5cxqbexy","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (d) Individuals other than the attorney, agent or inventor may comply\n with this section by disclosing information to the attorney, agent, or\n inventor.\n
    • ","rendered_text_plain":"(d) Individuals other than the attorney, agent or inventor may comply with this section by disclosing information to the attorney, agent, or inventor.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195526","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(d)","enumerator_ordinal":3,"parent_list_id":"ls_uxfb3h42"},{"id":"li_eqenbzjv","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_eqenbzjv","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (e) In any continuation-in-part application, the duty under this\n section includes the duty to disclose to the Office all information known to the\n person to be material to patentability, as defined in paragraph (b) of this\n section, which became available between the filing date of the prior application\n and the national or PCT international filing date of the continuation-in-part\n application.\n
    • ","rendered_text_plain":"(e) In any continuation-in-part application, the duty under this section includes the duty to disclose to the Office all information known to the person to be material to patentability, as defined in paragraph (b) of this section, which became available between the filing date of the prior application and the national or PCT international filing date of the continuation-in-part application.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195530","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(e)","enumerator_ordinal":4,"parent_list_id":"ls_uxfb3h42"},{"id":"sb_bfckhcyf","node_type":"statutory_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/sb_bfckhcyf","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195457","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","citation_title_text":"37 CFR 1.56","heading":"Duty to disclose information material to patentability.","body_list_id":"ls_uxfb3h42","host_section_id":"se_dyefh5xi"},{"id":"pb_f4337w7h","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_f4337w7h","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    [Editor Note: Para. (c)(3) below is applicable only to patent applications filed under 35 U.S.C. 111(a) or 363 on or after September 16, 2012.]

    ","rendered_text_plain":"[Editor Note: Para. (c)(3) below is applicable only to patent applications filed under 35 U.S.C. 111(a) or 363 on or after September 16, 2012.]","provenance":{"source_file":"s2001.html","source_anchor":"d0e195457/p.0","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_dyefh5xi","tags":["editorial_note"]},{"id":"ls_7u5lkrgq","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_7u5lkrgq","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_it_298db_1e09a_301","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"alpha_lower","nesting_depth":1,"host_section_id":"se_dyefh5xi","item_ids":["li_c4cs7463"],"parent_list_item_id":null},{"id":"ls_pwnutgei","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_pwnutgei","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_it_298db_1e153_13d","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"no_enumerator","nesting_depth":2,"host_section_id":"se_dyefh5xi","item_ids":["li_xoc6blba","li_velqynsh"],"parent_list_item_id":"li_c4cs7463"},{"id":"li_xoc6blba","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_xoc6blba","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • \n

    *****

    \n
    • ","rendered_text_plain":"*****","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_it_298db_1e153_13d","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"","enumerator_ordinal":0,"parent_list_id":"ls_pwnutgei"},{"id":"li_velqynsh","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_velqynsh","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (3) Every other person who is substantively\n involved in the preparation or prosecution of the application and who is\n associated with the inventor, with the assignee or with anyone to whom there\n is an obligation to assign the application.\n
    • ","rendered_text_plain":"(3) Every other person who is substantively involved in the preparation or prosecution of the application and who is associated with the inventor, with the assignee or with anyone to whom there is an obligation to assign the application.","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_it_298db_1e163_271","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(3)","enumerator_ordinal":1,"parent_list_id":"ls_pwnutgei"},{"id":"li_c4cs7463","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_c4cs7463","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"(c) Individuals associated with the filing or\n prosecution of a patent application within the meaning of this section are:\n ","rendered_text_plain":"(c) Individuals associated with the filing or prosecution of a patent application within the meaning of this section are:","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_it_298db_1e09a_301","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(c)","enumerator_ordinal":0,"parent_list_id":"ls_7u5lkrgq","child_ids":["ls_pwnutgei"]},{"id":"sb_bosalugb","node_type":"statutory_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/sb_bosalugb","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_d298db_1e016_321","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","citation_title_text":"37 CFR 1.56","heading":"Duty to disclose information material to patentability.","body_list_id":"ls_7u5lkrgq","host_section_id":"se_dyefh5xi"},{"id":"pb_crqyzva3","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_crqyzva3","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    [Editor Note: Para. (c)(3) below is not applicable to patent applications filed under 35 U.S.C. 111(a) or 363 on or after Sept. 16, 2012.]

    ","rendered_text_plain":"[Editor Note: Para. (c)(3) below is not applicable to patent applications filed under 35 U.S.C. 111(a) or 363 on or after Sept. 16, 2012.]","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_d298db_1e016_321/p.0","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_dyefh5xi","tags":["editorial_note"]},{"id":"pb_nww7tmrh","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_nww7tmrh","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    *****

    ","rendered_text_plain":"*****","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_d298db_1e016_321/p.1","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"excluded_text","host_section_id":"se_dyefh5xi","tags":["edit_history:excluded"]},{"id":"pb_lciirwhl","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_lciirwhl","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    37 CFR\n 1.56 defines the duty to disclose information to the Office.\n

    ","rendered_text_plain":"37 CFR 1.56 defines the duty to disclose information to the Office.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195534","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_dyefh5xi"},{"id":"ls_gbiktsj3","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_gbiktsj3","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195550","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"alpha_lower","nesting_depth":1,"host_section_id":"se_5hb4c2hn","item_ids":["li_gxkpsxf4"],"parent_list_item_id":null},{"id":"ls_n35wzo7h","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_n35wzo7h","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195554","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"arabic","nesting_depth":2,"host_section_id":"se_5hb4c2hn","item_ids":["li_gs2durbc","li_5jdm6b62","li_etmavd4i"],"parent_list_item_id":"li_gxkpsxf4"},{"id":"li_gs2durbc","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_gs2durbc","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (1) Each inventor named in the application;
    • ","rendered_text_plain":"(1) Each inventor named in the application;","provenance":{"source_file":"s2001.html","source_anchor":"d0e195554","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(1)","enumerator_ordinal":0,"parent_list_id":"ls_n35wzo7h"},{"id":"li_5jdm6b62","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_5jdm6b62","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (2) Each attorney or agent who prepares or prosecutes the\n application; and\n
    • ","rendered_text_plain":"(2) Each attorney or agent who prepares or prosecutes the application; and","provenance":{"source_file":"s2001.html","source_anchor":"d0e195558","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(2)","enumerator_ordinal":1,"parent_list_id":"ls_n35wzo7h"},{"id":"li_etmavd4i","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_etmavd4i","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (3) Every other person who is substantively involved in the\n preparation or prosecution of the application and who is associated with\n the inventor, the applicant, an assignee, or anyone to whom there is an\n obligation to assign the application.\n
    • ","rendered_text_plain":"(3) Every other person who is substantively involved in the preparation or prosecution of the application and who is associated with the inventor, the applicant, an assignee, or anyone to whom there is an obligation to assign the application.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195562","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(3)","enumerator_ordinal":2,"parent_list_id":"ls_n35wzo7h"},{"id":"li_gxkpsxf4","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_gxkpsxf4","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"(c) Individuals associated with the filing or prosecution of a\n patent application within the meaning of this section are:\n ","rendered_text_plain":"(c) Individuals associated with the filing or prosecution of a patent application within the meaning of this section are:","provenance":{"source_file":"s2001.html","source_anchor":"d0e195550","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(c)","enumerator_ordinal":0,"parent_list_id":"ls_gbiktsj3","child_ids":["ls_n35wzo7h"]},{"id":"sb_z6zsj7ds","node_type":"statutory_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/sb_z6zsj7ds","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195543","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","citation_title_text":"37 CFR 1.56","heading":"Duty to disclose information material to patentability.","body_list_id":"ls_gbiktsj3","host_section_id":"se_5hb4c2hn"},{"id":"pb_robgy4nm","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_robgy4nm","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    *****

    ","rendered_text_plain":"*****","provenance":{"source_file":"s2001.html","source_anchor":"d0e195543/p.0","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"excluded_text","host_section_id":"se_5hb4c2hn","tags":["edit_history:excluded"]},{"id":"pb_saroijsf","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_saroijsf","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    *****

    ","rendered_text_plain":"*****","provenance":{"source_file":"s2001.html","source_anchor":"d0e195543/p.1","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"excluded_text","host_section_id":"se_5hb4c2hn","tags":["edit_history:excluded"]},{"id":"ls_3wus22rm","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_3wus22rm","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e165550","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"alpha_lower","nesting_depth":1,"host_section_id":"se_5hb4c2hn","item_ids":["li_k5rvde27"],"parent_list_item_id":null},{"id":"ls_dfhv2tld","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_dfhv2tld","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e165554","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"arabic","nesting_depth":2,"host_section_id":"se_5hb4c2hn","item_ids":["li_t4ss7y4p","li_5pdwbsap","li_kwcvddho"],"parent_list_item_id":"li_k5rvde27"},{"id":"li_t4ss7y4p","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_t4ss7y4p","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (1) Each inventor named in the application;
    • ","rendered_text_plain":"(1) Each inventor named in the application;","provenance":{"source_file":"s2001.html","source_anchor":"d0e165554","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(1)","enumerator_ordinal":0,"parent_list_id":"ls_dfhv2tld"},{"id":"li_5pdwbsap","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_5pdwbsap","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (2) Each attorney or agent who prepares or prosecutes the\n application; and\n
    • ","rendered_text_plain":"(2) Each attorney or agent who prepares or prosecutes the application; and","provenance":{"source_file":"s2001.html","source_anchor":"d0e196558","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(2)","enumerator_ordinal":1,"parent_list_id":"ls_dfhv2tld"},{"id":"li_kwcvddho","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_kwcvddho","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (3) Every other person who is substantively involved in the\n preparation or prosecution of the application and who is associated with\n the inventor, with the assignee or with anyone to whom there is an\n obligation to assign the application.\n
    • ","rendered_text_plain":"(3) Every other person who is substantively involved in the preparation or prosecution of the application and who is associated with the inventor, with the assignee or with anyone to whom there is an obligation to assign the application.","provenance":{"source_file":"s2001.html","source_anchor":"d0e165562","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(3)","enumerator_ordinal":2,"parent_list_id":"ls_dfhv2tld"},{"id":"li_k5rvde27","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_k5rvde27","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"(c) Individuals associated with the filing or prosecution of a\n patent application within the meaning of this section are:\n ","rendered_text_plain":"(c) Individuals associated with the filing or prosecution of a patent application within the meaning of this section are:","provenance":{"source_file":"s2001.html","source_anchor":"d0e165550","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(c)","enumerator_ordinal":0,"parent_list_id":"ls_3wus22rm","child_ids":["ls_dfhv2tld"]},{"id":"sb_tzy6o6na","node_type":"statutory_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/sb_tzy6o6na","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195643","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","citation_title_text":"37 CFR 1.56","heading":"Duty to disclose information material to patentability.","body_list_id":"ls_3wus22rm","host_section_id":"se_5hb4c2hn"},{"id":"pb_2oa3pizx","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_2oa3pizx","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    *****

    ","rendered_text_plain":"*****","provenance":{"source_file":"s2001.html","source_anchor":"d0e195643/p.0","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"excluded_text","host_section_id":"se_5hb4c2hn","tags":["edit_history:excluded"]},{"id":"pb_akjpooxh","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_akjpooxh","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    *****

    ","rendered_text_plain":"*****","provenance":{"source_file":"s2001.html","source_anchor":"d0e195643/p.1","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"excluded_text","host_section_id":"se_5hb4c2hn","tags":["edit_history:excluded"]},{"id":"pb_hnhcsilf","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_hnhcsilf","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    The duty to disclose applies to matters pending before the USPTO and\n extends broadly to “[e]ach individual associated with the filing and prosecution of a\n patent application” and “[e]ach individual associated with the patent owner in a\n reexamination proceeding.” 37 CFR 1.56(c) and 1.555(a). For\n patent applications, including reissue applications, these individuals include each\n inventor named in the application, each attorney or agent who prepares or prosecutes the\n application, and “[e]very other person who is substantively involved in the preparation\n or prosecution of the application and who is associated with the inventor, the\n applicant, an assignee, or anyone to whom there is an obligation to assign the\n application.” This is intended to make clear that the duty does not extend to typists,\n clerks, and similar personnel who assist with an application. For reexamination\n proceedings, these individuals include “the patent owner, each attorney or agent who\n represents the patent owner, and every other individual who is substantively involved on\n behalf of the patent owner in a reexamination proceeding.” 37 CFR\n 1.555(a).\n

    ","rendered_text_plain":"The duty to disclose applies to matters pending before the USPTO and extends broadly to “[e]ach individual associated with the filing and prosecution of a patent application” and “[e]ach individual associated with the patent owner in a reexamination proceeding.” 37 CFR 1.56(c) and 1.555(a). For patent applications, including reissue applications, these individuals include each inventor named in the application, each attorney or agent who prepares or prosecutes the application, and “[e]very other person who is substantively involved in the preparation or prosecution of the application and who is associated with the inventor, the applicant, an assignee, or anyone to whom there is an obligation to assign the application.” This is intended to make clear that the duty does not extend to typists, clerks, and similar personnel who assist with an application. For reexamination proceedings, these individuals include “the patent owner, each attorney or agent who represents the patent owner, and every other individual who is substantively involved on behalf of the patent owner in a reexamination proceeding.” 37 CFR 1.555(a).","provenance":{"source_file":"s2001.html","source_anchor":"d0e195568","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_5hb4c2hn"},{"id":"pb_g25sgdio","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_g25sgdio","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    The duty of disclosure applies only to individuals, not to\n organizations. For instance, the duty of disclosure would not apply to a corporation or\n institution as such. However, it would apply to individuals within the corporation or\n institution who were substantively involved in the preparation or prosecution of the\n application, and actions by such individuals may affect the rights of the corporation or\n institution. \n

    ","rendered_text_plain":"The duty of disclosure applies only to individuals, not to organizations. For instance, the duty of disclosure would not apply to a corporation or institution as such. However, it would apply to individuals within the corporation or institution who were substantively involved in the preparation or prosecution of the application, and actions by such individuals may affect the rights of the corporation or institution.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195571","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_5hb4c2hn"},{"id":"pb_izxqdjbj","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_izxqdjbj","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_d22347_29e69_109","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"decorative","host_section_id":"se_ozog5fuk","tags":["validation:decorative_empty"]},{"id":"pb_vzxdktxo","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_vzxdktxo","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    37 CFR\n 1.56(a) states that the “duty of candor and good faith” is owed\n “in dealing with the Office” and that all associated with the filing and prosecution of\n a patent application have a “duty to disclose to the Office” material information. This\n duty “in dealing with” and “to” the Office extends, of course, to all dealings which\n such individuals have with the Office, and is not limited to representations to or\n dealings with the examiner. For example, the duty would extend to proceedings before the\n Patent Trial and Appeal Board and the Office of the Commissioner for Patents.\n

    ","rendered_text_plain":"37 CFR 1.56(a) states that the “duty of candor and good faith” is owed “in dealing with the Office” and that all associated with the filing and prosecution of a patent application have a “duty to disclose to the Office” material information. This duty “in dealing with” and “to” the Office extends, of course, to all dealings which such individuals have with the Office, and is not limited to representations to or dealings with the examiner. For example, the duty would extend to proceedings before the Patent Trial and Appeal Board and the Office of the Commissioner for Patents.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195578","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_bsmwel2l"},{"id":"ls_wkvtcnj4","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_wkvtcnj4","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195598","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"alpha_lower","nesting_depth":1,"host_section_id":"se_cuxefq5m","item_ids":["li_y4ibx6c4"],"parent_list_item_id":null},{"id":"ls_nml7o5pd","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_nml7o5pd","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195608","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"arabic","nesting_depth":2,"host_section_id":"se_cuxefq5m","item_ids":["li_7rgv4df4","li_vped4szp"],"parent_list_item_id":"li_y4ibx6c4"},{"id":"li_7rgv4df4","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_7rgv4df4","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (1) Prior art cited in search reports of a foreign patent\n office in a counterpart application, and\n
    • ","rendered_text_plain":"(1) Prior art cited in search reports of a foreign patent office in a counterpart application, and","provenance":{"source_file":"s2001.html","source_anchor":"d0e195608","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(1)","enumerator_ordinal":0,"parent_list_id":"ls_nml7o5pd"},{"id":"li_vped4szp","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_vped4szp","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (2) The closest information over which individuals\n associated with the filing or prosecution of a patent application believe\n any pending claim patentably defines, to make sure that any material\n information contained therein is disclosed to the Office.\n
    • ","rendered_text_plain":"(2) The closest information over which individuals associated with the filing or prosecution of a patent application believe any pending claim patentably defines, to make sure that any material information contained therein is disclosed to the Office.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195612","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(2)","enumerator_ordinal":1,"parent_list_id":"ls_nml7o5pd"},{"id":"li_y4ibx6c4","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_y4ibx6c4","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"(a) A patent by its very nature is affected with a public\n interest. The public interest is best served, and the most effective patent\n examination occurs when, at the time an application is being examined, the\n Office is aware of and evaluates the teachings of all information material to\n patentability. Each individual associated with the filing and prosecution of a\n patent application has a duty of candor and good faith in dealing with the\n Office, which includes a duty to disclose to the Office all information known\n to that individual to be material to patentability as defined in this section.\n The duty to disclose information exists with respect to each pending claim\n until the claim is cancelled or withdrawn from consideration, or the\n application becomes abandoned. Information material to the patentability of a\n claim that is cancelled or withdrawn from consideration need not be submitted\n if the information is not material to the patentability of any claim remaining\n under consideration in the application. There is no duty to submit information\n which is not material to the patentability of any existing claim. The duty to\n disclose all information known to be material to patentability is deemed to be\n satisfied if all information known to be material to patentability of any claim\n issued in a patent was cited by the Office or submitted to the Office in the\n manner prescribed by §§\n 1.97(b)-(d) and 1.98.\n However, no patent will be granted on an application in connection with which\n fraud on the Office was practiced or attempted or the duty of disclosure was\n violated through bad faith or intentional misconduct. The Office encourages\n applicants to carefully examine:\n ","rendered_text_plain":"(a) A patent by its very nature is affected with a public interest. The public interest is best served, and the most effective patent examination occurs when, at the time an application is being examined, the Office is aware of and evaluates the teachings of all information material to patentability. Each individual associated with the filing and prosecution of a patent application has a duty of candor and good faith in dealing with the Office, which includes a duty to disclose to the Office all information known to that individual to be material to patentability as defined in this section. The duty to disclose information exists with respect to each pending claim until the claim is cancelled or withdrawn from consideration, or the application becomes abandoned. Information material to the patentability of a claim that is cancelled or withdrawn from consideration need not be submitted if the information is not material to the patentability of any claim remaining under consideration in the application. There is no duty to submit information which is not material to the patentability of any existing claim. The duty to disclose all information known to be material to patentability is deemed to be satisfied if all information known to be material to patentability of any claim issued in a patent was cited by the Office or submitted to the Office in the manner prescribed by §§ 1.97(b)-(d) and 1.98. However, no patent will be granted on an application in connection with which fraud on the Office was practiced or attempted or the duty of disclosure was violated through bad faith or intentional misconduct. The Office encourages applicants to carefully examine:","provenance":{"source_file":"s2001.html","source_anchor":"d0e195598","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(a)","enumerator_ordinal":0,"parent_list_id":"ls_wkvtcnj4","child_ids":["ls_nml7o5pd"]},{"id":"sb_t3mgsvbt","node_type":"statutory_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/sb_t3mgsvbt","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195589","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","citation_title_text":"37 CFR 1.56","heading":"Duty to disclose information material to patentability.","body_list_id":"ls_wkvtcnj4","host_section_id":"se_cuxefq5m"},{"id":"pb_q5b2lacb","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_q5b2lacb","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    *****

    ","rendered_text_plain":"*****","provenance":{"source_file":"s2001.html","source_anchor":"d0e195589/p.0","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"excluded_text","host_section_id":"se_cuxefq5m","tags":["edit_history:excluded"]},{"id":"pb_5fkbbah4","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_5fkbbah4","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    The language of 37 CFR 1.56 (and 37 CFR 1.555)\n emphasizes that there is a duty of candor and good faith which is broader than the duty\n to disclose material information. 37 CFR 1.56 further states that “no\n patent will be granted on an application in connection with which fraud on the Office\n was practiced or attempted or the duty of disclosure was violated through bad faith or\n intentional misconduct.” Specifically, the duty of candor and good faith, and by\n extension the duty to disclose, applies to positions taken by applicants or parties\n involving the claimed subject matter.\n

    ","rendered_text_plain":"The language of 37 CFR 1.56 (and 37 CFR 1.555) emphasizes that there is a duty of candor and good faith which is broader than the duty to disclose material information. 37 CFR 1.56 further states that “no patent will be granted on an application in connection with which fraud on the Office was practiced or attempted or the duty of disclosure was violated through bad faith or intentional misconduct.” Specifically, the duty of candor and good faith, and by extension the duty to disclose, applies to positions taken by applicants or parties involving the claimed subject matter.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195618","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"pb_42ureqy5","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_42ureqy5","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    If a party to a USPTO proceeding discovers that an\n earlier position taken in a submission to the USPTO or another Government agency was\n incorrect or inconsistent with other statements made by the party, the party must\n promptly correct the record. See, e.g., In re Tendler, Proceeding No.\n D2013-17 (USPTO Jan. 1, 2014) (suspending a practitioner for four years for failure to\n correct the written record after learning of inaccuracies in a declaration the\n practitioner had filed). In the context of prosecution, an applicant must disclose to\n the USPTO any information that refutes, or is inconsistent with, a position the\n applicant takes in: (i) opposing an argument of unpatentability relied on by the Office,\n or (ii) asserting an argument of patentability. See 37 CFR\n 1.56(b)(2). Patent owners may bring information, including prior\n art and incorrect or inconsistent positions, to the attention of the USPTO through\n supplemental examination, ex parte reexamination, reissue\n applications, or submissions under 37 CFR 1.501. During prosecution,\n third parties may have an opportunity to disclose information to the USPTO through third\n party submissions under 37 CFR 1.290 and protests under\n 37 CFR\n 1.291. After issuance, third parties may disclose information\n directed to issued patents to the USPTO via submissions under 37 CFR 1.501, or\n in ex parte reexamination. A finding of “fraud,” “inequitable\n conduct,” or violation of duty of disclosure through bad faith or intentional misconduct\n with respect to any claim in an application or patent, renders all the claims thereof\n unpatentable or invalid. See MPEP § 2016.\n

    ","rendered_text_plain":"If a party to a USPTO proceeding discovers that an earlier position taken in a submission to the USPTO or another Government agency was incorrect or inconsistent with other statements made by the party, the party must promptly correct the record. See, e.g., In re Tendler, Proceeding No. D2013-17 (USPTO Jan. 1, 2014) (suspending a practitioner for four years for failure to correct the written record after learning of inaccuracies in a declaration the practitioner had filed). In the context of prosecution, an applicant must disclose to the USPTO any information that refutes, or is inconsistent with, a position the applicant takes in: (i) opposing an argument of unpatentability relied on by the Office, or (ii) asserting an argument of patentability. See 37 CFR 1.56(b)(2). Patent owners may bring information, including prior art and incorrect or inconsistent positions, to the attention of the USPTO through supplemental examination, ex parte reexamination, reissue applications, or submissions under 37 CFR 1.501. During prosecution, third parties may have an opportunity to disclose information to the USPTO through third party submissions under 37 CFR 1.290 and protests under 37 CFR 1.291. After issuance, third parties may disclose information directed to issued patents to the USPTO via submissions under 37 CFR 1.501, or in ex parte reexamination. A finding of “fraud,” “inequitable conduct,” or violation of duty of disclosure through bad faith or intentional misconduct with respect to any claim in an application or patent, renders all the claims thereof unpatentable or invalid. See MPEP § 2016.","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18c9a_fe","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"se_7xa3kxa7","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_7xa3kxa7","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-2016","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2016","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2016","section_number":"2016","chapter":"2000","depth":0,"title":"Section 2016","children_ids":[]},{"id":"pb_uh4v4dgv","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_uh4v4dgv","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    The Office strives to issue valid patents. The Office has both an\n obligation not to unjustly issue patents and an obligation not to unjustly deny patents.\n Innovation and technological advancement are best served when an inventor is issued a\n patent with the scope of protection that is deserved. The rules serve to remind\n individuals associated with the preparation and prosecution of patent applications of\n their duty of candor and good faith in their dealings with the Office, and will aid the\n Office in receiving, in a timely manner, the information it needs to carry out effective\n and efficient examination of patent applications. Moreover, an incentive exists to\n submit material information to the Office because it may result in enhanced patent\n quality and may avoid later questions of materiality and intent to deceive.\n

    ","rendered_text_plain":"The Office strives to issue valid patents. The Office has both an obligation not to unjustly issue patents and an obligation not to unjustly deny patents. Innovation and technological advancement are best served when an inventor is issued a patent with the scope of protection that is deserved. The rules serve to remind individuals associated with the preparation and prosecution of patent applications of their duty of candor and good faith in their dealings with the Office, and will aid the Office in receiving, in a timely manner, the information it needs to carry out effective and efficient examination of patent applications. Moreover, an incentive exists to submit material information to the Office because it may result in enhanced patent quality and may avoid later questions of materiality and intent to deceive.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195630","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"pb_t5drfrlx","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_t5drfrlx","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    The definition of materiality in 37 CFR 1.56 is intended to provide\n the Office with the information it needs in order for the examiner to make a proper and\n independent determination on patentability. The patent examiner should make the\n patentability determination after considering the relevant facts properly of record in\n the particular case.\n

    ","rendered_text_plain":"The definition of materiality in 37 CFR 1.56 is intended to provide the Office with the information it needs in order for the examiner to make a proper and independent determination on patentability. The patent examiner should make the patentability determination after considering the relevant facts properly of record in the particular case.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195646","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"pb_wltefpvy","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_wltefpvy","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    37 CFR\n 1.56 states that each individual associated with the filing and\n prosecution of a patent application has a duty to disclose all information known to that\n individual to be material to patentability as defined in the section. Thus, the duty\n applies to contemporaneously or presently known information. The fact that information\n was known years ago does not mean that it was recognized that the information is\n material to the present application.\n

    ","rendered_text_plain":"37 CFR 1.56 states that each individual associated with the filing and prosecution of a patent application has a duty to disclose all information known to that individual to be material to patentability as defined in the section. Thus, the duty applies to contemporaneously or presently known information. The fact that information was known years ago does not mean that it was recognized that the information is material to the present application.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195652","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"pb_vvpsvooy","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_vvpsvooy","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    The term “information” as used in 37 CFR 1.56 means all of the kinds\n of information required to be disclosed and includes any information which is “material\n to patentability.” Materiality is defined in 37 CFR 1.56(b) and discussed herein\n at MPEP\n § 2001.05. In addition to prior art such as patents and\n publications, 37 CFR\n 1.56 includes, for example, information on enablement, possible\n prior public uses, sales, offers to sell, derived knowledge, prior invention by another,\n inventorship conflicts, litigation statements, and the like. “Materiality is not limited\n to prior art but embraces any information that a reasonable examiner\n would be substantially likely to consider important in deciding whether to allow an\n application to issue as a patent.” Bristol-Myers Squibb Co. v. Rhone-Poulenc\n Rorer, Inc., 326 F.3d 1226, 1234, 66 USPQ2d 1481, 1486 (Fed. Cir. 2003)\n (emphasis in original) (finding article which was not prior art to be material to\n enablement issue).\n

    ","rendered_text_plain":"The term “information” as used in 37 CFR 1.56 means all of the kinds of information required to be disclosed and includes any information which is “material to patentability.” Materiality is defined in 37 CFR 1.56(b) and discussed herein at MPEP § 2001.05. In addition to prior art such as patents and publications, 37 CFR 1.56 includes, for example, information on enablement, possible prior public uses, sales, offers to sell, derived knowledge, prior invention by another, inventorship conflicts, litigation statements, and the like. “Materiality is not limited to prior art but embraces any information that a reasonable examiner would be substantially likely to consider important in deciding whether to allow an application to issue as a patent.” Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc., 326 F.3d 1226, 1234, 66 USPQ2d 1481, 1486 (Fed. Cir. 2003) (emphasis in original) (finding article which was not prior art to be material to enablement issue).","provenance":{"source_file":"s2001.html","source_anchor":"d0e195657","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"pb_shn7jew4","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_shn7jew4","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    Patent examiners also have the ability to require\n submission of information that may be reasonably necessary to properly examine or treat\n a matter in a pending or abandoned application, but not necessarily “material to\n patentability.” 37\n CFR 1.105(a)(1). The information that must be submitted to comply\n with a requirement for information under 37 CFR 1.105 may not be material to\n patentability in itself under 37 CFR 1.56, but it is necessary to\n obtain a complete record from which a determination of patentability may be made. See\n MPEP §\n 704.12(a). Therefore, when an examiner has a reasonable basis\n to conclude that an individual identified under 37 CFR 1.56(c) or any assignee has\n information that would aid in the examination of the application or treatment of some\n matter, the examiner may require submission of information that is not necessarily\n material to patentability. This requirement could include statements made or information\n submitted to other Government agencies such as the FDA. See MPEP §\n 2015. For example, when examining a claim directed to a\n process of manufacturing a particular drug product that was effectively filed more than\n one year after FDA approval of the drug product, an examiner may appropriately require\n an applicant to submit to the USPTO information submitted to the FDA (e.g., in a New\n Drug Application or Biologics License Application) on how the drug product was\n manufactured.\n

    ","rendered_text_plain":"Patent examiners also have the ability to require submission of information that may be reasonably necessary to properly examine or treat a matter in a pending or abandoned application, but not necessarily “material to patentability.” 37 CFR 1.105(a)(1). The information that must be submitted to comply with a requirement for information under 37 CFR 1.105 may not be material to patentability in itself under 37 CFR 1.56, but it is necessary to obtain a complete record from which a determination of patentability may be made. See MPEP § 704.12(a). Therefore, when an examiner has a reasonable basis to conclude that an individual identified under 37 CFR 1.56(c) or any assignee has information that would aid in the examination of the application or treatment of some matter, the examiner may require submission of information that is not necessarily material to patentability. This requirement could include statements made or information submitted to other Government agencies such as the FDA. See MPEP § 2015. For example, when examining a claim directed to a process of manufacturing a particular drug product that was effectively filed more than one year after FDA approval of the drug product, an examiner may appropriately require an applicant to submit to the USPTO information submitted to the FDA (e.g., in a New Drug Application or Biologics License Application) on how the drug product was manufactured.","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18eda_145","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"se_n3cepdog","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_n3cepdog","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-704","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_704","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_704","section_number":"704","chapter":"700","depth":0,"title":"Section 704","children_ids":[]},{"id":"se_vj6nqkne","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_vj6nqkne","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-2015","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2015","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2015","section_number":"2015","chapter":"2000","depth":0,"title":"Section 2015","children_ids":[]},{"id":"pb_otisysyv","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_otisysyv","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    The term “information” is intended to be all encompassing, similar to\n the scope of the term as discussed with respect to 37 CFR 1.291(a) (see\n MPEP\n § 1901.02). 37 CFR 1.56(a) also states: “The\n Office encourages applicants to carefully examine: (1) prior art cited in search reports\n of a foreign patent office in a counterpart application, and (2) the closest information\n over which individuals associated with the filing or prosecution of a patent application\n believe any pending claim patentably defines, to make sure that any material information\n contained therein is disclosed to the Office.”\n

    ","rendered_text_plain":"The term “information” is intended to be all encompassing, similar to the scope of the term as discussed with respect to 37 CFR 1.291(a) (see MPEP § 1901.02). 37 CFR 1.56(a) also states: “The Office encourages applicants to carefully examine: (1) prior art cited in search reports of a foreign patent office in a counterpart application, and (2) the closest information over which individuals associated with the filing or prosecution of a patent application believe any pending claim patentably defines, to make sure that any material information contained therein is disclosed to the Office.”","provenance":{"source_file":"s2001.html","source_anchor":"d0e195685","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"se_m3lq2fhz","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_m3lq2fhz","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-1901","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_1901","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_1901","section_number":"1901","chapter":"1900","depth":0,"title":"Section 1901","children_ids":[]},{"id":"pb_mj3amqhn","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_mj3amqhn","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    It should be noted that the rules are not intended\n to require information favorable to patentability such as, for\n example, evidence of commercial success of the invention. Similarly, the rules are not\n intended to require, for example, disclosure of information concerning the level of\n skill in the art for purposes of determining obviousness.\n

    ","rendered_text_plain":"It should be noted that the rules are not intended to require information favorable to patentability such as, for example, evidence of commercial success of the invention. Similarly, the rules are not intended to require, for example, disclosure of information concerning the level of skill in the art for purposes of determining obviousness.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195697","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"pb_lm6z5iv4","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_lm6z5iv4","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    37 CFR\n 1.56(a) states that the duty to disclose information exists until\n the application becomes abandoned. The duty to disclose information, however, does not\n end when an application becomes allowed but extends until a patent is granted on that\n application. The rules provide for information being considered after a notice of\n allowance is mailed and before the issue fee is paid (37 CFR 1.97(d))\n (see MPEP § 609.04(b),\n subsection III). The rules also provide for an application to\n be withdrawn from issue:\n

    ","rendered_text_plain":"37 CFR 1.56(a) states that the duty to disclose information exists until the application becomes abandoned. The duty to disclose information, however, does not end when an application becomes allowed but extends until a patent is granted on that application. The rules provide for information being considered after a notice of allowance is mailed and before the issue fee is paid (37 CFR 1.97(d)) (see MPEP § 609.04(b), subsection III). The rules also provide for an application to be withdrawn from issue:","provenance":{"source_file":"s2001.html","source_anchor":"d0e195706","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"se_ql6l6rdc","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_ql6l6rdc","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-609","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_609","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_609","section_number":"609","chapter":"600","depth":0,"title":"Section 609","children_ids":[]},{"id":"ls_hsxdcjka","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_hsxdcjka","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195718","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"alpha_upper","nesting_depth":1,"host_section_id":"se_cuxefq5m","item_ids":["li_5fis55ud","li_ovehpgog","li_ow2kpjlb"],"parent_list_item_id":null},{"id":"li_5fis55ud","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_5fis55ud","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (A) because one or more claims are unpatentable (37 CFR\n 1.313(c)(1));\n
    • ","rendered_text_plain":"(A) because one or more claims are unpatentable (37 CFR 1.313(c)(1));","provenance":{"source_file":"s2001.html","source_anchor":"d0e195718","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(A)","enumerator_ordinal":0,"parent_list_id":"ls_hsxdcjka"},{"id":"li_ovehpgog","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_ovehpgog","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (B) for express abandonment so that information may be considered in\n a continuing application before a patent issues (37 CFR\n 1.313(c)(3)); or \n
    • ","rendered_text_plain":"(B) for express abandonment so that information may be considered in a continuing application before a patent issues (37 CFR 1.313(c)(3)); or","provenance":{"source_file":"s2001.html","source_anchor":"d0e195725","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(B)","enumerator_ordinal":1,"parent_list_id":"ls_hsxdcjka"},{"id":"li_ow2kpjlb","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_ow2kpjlb","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (C) for consideration of a request for continued examination (RCE)\n under 37 CFR\n 1.114 (37 CFR 1.313(a) and\n (c)(2)). Note that RCE practice does not apply to utility\n or plant applications filed before June 8, 1995 or to design applications. See\n MPEP §\n 706.07(h).\n
    • ","rendered_text_plain":"(C) for consideration of a request for continued examination (RCE) under 37 CFR 1.114 (37 CFR 1.313(a) and (c)(2)). Note that RCE practice does not apply to utility or plant applications filed before June 8, 1995 or to design applications. See MPEP § 706.07(h).","provenance":{"source_file":"s2001.html","source_anchor":"d0e195732","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(C)","enumerator_ordinal":2,"parent_list_id":"ls_hsxdcjka"},{"id":"se_wfpxd3yo","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_wfpxd3yo","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-706","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_706","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_706","section_number":"706","chapter":"700","depth":0,"title":"Section 706","children_ids":[]},{"id":"pb_5tavpib3","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_5tavpib3","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    See MPEP\n § 1308 for additional information pertaining to withdrawal of\n an application from issue.\n

    ","rendered_text_plain":"See MPEP § 1308 for additional information pertaining to withdrawal of an application from issue.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195745","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"se_mujtnnwg","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_mujtnnwg","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-1308","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_1308","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_1308","section_number":"1308","chapter":"1300","depth":0,"title":"Section 1308","children_ids":[]},{"id":"pb_gyopr5lp","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_gyopr5lp","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    In a continuation-in-part application, individuals covered by\n 37 CFR\n 1.56 have a duty to disclose to the Office all information known\n to be material to patentability which became available between the filing date of the\n prior application and the national or PCT international filing date of the\n continuation-in-part application. See 37 CFR 1.56(e).\n

    ","rendered_text_plain":"In a continuation-in-part application, individuals covered by 37 CFR 1.56 have a duty to disclose to the Office all information known to be material to patentability which became available between the filing date of the prior application and the national or PCT international filing date of the continuation-in-part application. See 37 CFR 1.56(e).","provenance":{"source_file":"s2001.html","source_anchor":"d0e195751","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"pb_raw3c6uh","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_raw3c6uh","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    37 CFR\n 1.56 provides that the duty of disclosure can be met by submitting\n information to the Office in the manner prescribed by 37 CFR 1.97 and\n 1.98. See MPEP § 609et seq. Applicants are provided certainty as to when information will\n be considered, and applicants will be informed when information is not considered. Note,\n however, if even a document was cited to or considered in a prior examination or related\n Office proceeding, the Office may order reexamination based on the document if it raises\n a substantial new question of patentability. See MPEP § 2242 and MPEP § 2258.01.\n

    ","rendered_text_plain":"37 CFR 1.56 provides that the duty of disclosure can be met by submitting information to the Office in the manner prescribed by 37 CFR 1.97 and 1.98. See MPEP § 609et seq. Applicants are provided certainty as to when information will be considered, and applicants will be informed when information is not considered. Note, however, if even a document was cited to or considered in a prior examination or related Office proceeding, the Office may order reexamination based on the document if it raises a substantial new question of patentability. See MPEP § 2242 and MPEP § 2258.01.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195763","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"se_siblb6xz","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_siblb6xz","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-2242","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2242","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2242","section_number":"2242","chapter":"2200","depth":0,"title":"Section 2242","children_ids":[]},{"id":"se_32rnaq3e","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_32rnaq3e","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-2258","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2258","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2258","section_number":"2258","chapter":"2200","depth":0,"title":"Section 2258","children_ids":[]},{"id":"pb_mymzesyu","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_mymzesyu","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    37 CFR 1.555 provides for the duty\n of disclosure in reexamination proceedings. For a discussion of information material to\n patentability in a reexamination proceeding, see MPEP § 2280 or MPEP § 2684. For\n supplemental examination and any ex parte reexamination proceeding\n ordered under 35 U.S.C. 257, information material\n to patentability is defined by 37 CFR 1.56. See 37 CFR\n 1.625(d)(4) and MPEP §\n 2820.\n

    ","rendered_text_plain":"37 CFR 1.555 provides for the duty of disclosure in reexamination proceedings. For a discussion of information material to patentability in a reexamination proceeding, see MPEP § 2280 or MPEP § 2684. For supplemental examination and any ex parte reexamination proceeding ordered under 35 U.S.C. 257, information material to patentability is defined by 37 CFR 1.56. See 37 CFR 1.625(d)(4) and MPEP § 2820.","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_298db_200b3_1fb","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_cuxefq5m"},{"id":"se_mcwwdtbj","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_mcwwdtbj","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-2280","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2280","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2280","section_number":"2280","chapter":"2200","depth":0,"title":"Section 2280","children_ids":[]},{"id":"se_5ssvsirp","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_5ssvsirp","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-2684","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2684","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2684","section_number":"2684","chapter":"2600","depth":0,"title":"Section 2684","children_ids":[]},{"id":"se_ossiva7v","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_ossiva7v","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-2820","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2820","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2820","section_number":"2820","chapter":"2800","depth":0,"title":"Section 2820","children_ids":[]},{"id":"ls_ofk3whza","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_ofk3whza","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195825","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"alpha_lower","nesting_depth":1,"host_section_id":"se_rlnwhhop","item_ids":["li_s7pg7nri"],"parent_list_item_id":null},{"id":"ls_v4srg53d","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_v4srg53d","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195829","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"arabic","nesting_depth":2,"host_section_id":"se_rlnwhhop","item_ids":["li_iok2zsw4","li_fsegre3o"],"parent_list_item_id":"li_s7pg7nri"},{"id":"li_iok2zsw4","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_iok2zsw4","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (1) It establishes, by itself or in combination with other\n information, a prima facie case of unpatentability of\n a claim; or\n
    • ","rendered_text_plain":"(1) It establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or","provenance":{"source_file":"s2001.html","source_anchor":"d0e195829","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(1)","enumerator_ordinal":0,"parent_list_id":"ls_v4srg53d"},{"id":"ls_lb2ud3cm","node_type":"list","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/ls_lb2ud3cm","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195840","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_style":"roman_lower","nesting_depth":3,"host_section_id":"se_rlnwhhop","item_ids":["li_kuvmv3qw","li_d22efatz"],"parent_list_item_id":"li_fsegre3o"},{"id":"li_kuvmv3qw","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_kuvmv3qw","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (i) Opposing an argument of unpatentability relied on\n by the Office, or\n
    • ","rendered_text_plain":"(i) Opposing an argument of unpatentability relied on by the Office, or","provenance":{"source_file":"s2001.html","source_anchor":"d0e195840","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(i)","enumerator_ordinal":0,"parent_list_id":"ls_lb2ud3cm"},{"id":"li_d22efatz","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_d22efatz","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
  • (ii) Asserting an argument of patentability.
    • ","rendered_text_plain":"(ii) Asserting an argument of patentability.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195844","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(ii)","enumerator_ordinal":1,"parent_list_id":"ls_lb2ud3cm"},{"id":"li_fsegre3o","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_fsegre3o","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"(2) It refutes, or is inconsistent with, a position the\n applicant takes in:\n ","rendered_text_plain":"(2) It refutes, or is inconsistent with, a position the applicant takes in:","provenance":{"source_file":"s2001.html","source_anchor":"d0e195836","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(2)","enumerator_ordinal":1,"parent_list_id":"ls_v4srg53d","child_ids":["ls_lb2ud3cm"]},{"id":"li_s7pg7nri","node_type":"list_item","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/li_s7pg7nri","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"(b) Under this section, information is material to patentability\n when it is not cumulative to information already of record or being made of\n record in the application, and\n ","rendered_text_plain":"(b) Under this section, information is material to patentability when it is not cumulative to information already of record or being made of record in the application, and","provenance":{"source_file":"s2001.html","source_anchor":"d0e195825","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"enumerator_label":"(b)","enumerator_ordinal":0,"parent_list_id":"ls_ofk3whza","child_ids":["ls_v4srg53d"]},{"id":"sb_tysaiziu","node_type":"statutory_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/sb_tysaiziu","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"d0e195814","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","citation_title_text":"37 CFR 1.56","heading":"Duty to disclose information material to patent ability.","body_list_id":"ls_ofk3whza","host_section_id":"se_rlnwhhop"},{"id":"pb_yqwjusoz","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_yqwjusoz","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    *****

    ","rendered_text_plain":"*****","provenance":{"source_file":"s2001.html","source_anchor":"d0e195814/p.0","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"excluded_text","host_section_id":"se_rlnwhhop","tags":["edit_history:excluded"]},{"id":"pb_vvga4maw","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_vvga4maw","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    A prima facie case of unpatentability is\n established when the information compels a conclusion that a claim is unpatentable\n under the preponderance of evidence, burden-of-proof standard, giving each term in\n the claim its broadest reasonable construction consistent with the specification, and\n before any consideration is given to evidence which may be submitted in an attempt to\n establish a contrary conclusion of patentability.\n

    ","rendered_text_plain":"A prima facie case of unpatentability is established when the information compels a conclusion that a claim is unpatentable under the preponderance of evidence, burden-of-proof standard, giving each term in the claim its broadest reasonable construction consistent with the specification, and before any consideration is given to evidence which may be submitted in an attempt to establish a contrary conclusion of patentability.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195848","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_rlnwhhop"},{"id":"pb_usppjpte","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_usppjpte","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    *****

    ","rendered_text_plain":"*****","provenance":{"source_file":"s2001.html","source_anchor":"d0e195814/p.2","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"excluded_text","host_section_id":"se_rlnwhhop","tags":["edit_history:excluded"]},{"id":"pb_vgvxkuf7","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_vgvxkuf7","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    Under the rule, information is not material unless it comes within the\n definition of 37\n CFR 1.56(b)(1) or (2). Generally, when information is\n clearly cumulative or not material, there is no duty to disclose the information to the\n Office. “[I]nformation is material to patentability when it is not cumulative to\n information already of record or being made of record in the application, and (1) It\n establishes, by itself or in combination with other information, a prima\n facie case of unpatentability of a claim; or (2) It refutes, or is\n inconsistent with, a position the applicant takes in: (i) Opposing an argument of\n unpatentability relied on by the Office, or (ii) Asserting an argument of\n patentability.” 37\n CFR 1.56(b). In close cases where the materiality or consistency\n of the information is in question, the applicant should consider submitting this\n information to the USPTO. The Office believes that most applicants will wish to submit\n the information even though they may not be required to do so, to strengthen the patent\n and avoid the risks of an incorrect judgment on their part on materiality. The USPTO\n holds those individuals subject to this duty to the highest standards.\n

    ","rendered_text_plain":"Under the rule, information is not material unless it comes within the definition of 37 CFR 1.56(b)(1) or (2). Generally, when information is clearly cumulative or not material, there is no duty to disclose the information to the Office. “[I]nformation is material to patentability when it is not cumulative to information already of record or being made of record in the application, and (1) It establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or (2) It refutes, or is inconsistent with, a position the applicant takes in: (i) Opposing an argument of unpatentability relied on by the Office, or (ii) Asserting an argument of patentability.” 37 CFR 1.56(b). In close cases where the materiality or consistency of the information is in question, the applicant should consider submitting this information to the USPTO. The Office believes that most applicants will wish to submit the information even though they may not be required to do so, to strengthen the patent and avoid the risks of an incorrect judgment on their part on materiality. The USPTO holds those individuals subject to this duty to the highest standards.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195856","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_rlnwhhop"},{"id":"pb_mawk3sgk","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_mawk3sgk","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    All individuals covered by 37 CFR 1.56 (reproduced in\n MPEP §\n 2001.01) have a duty to disclose to the U.S. Patent and\n Trademark Office all material information they are aware of\n regardless of the source of or how they become aware of the information. See\n Brasseler, U.S.A. I, L.P. v. Stryker Sales Corp., 267 F.3d 1370,\n 1383, 60 USPQ2d 1482, 1490 (Fed. Cir. 2001) (“Once an attorney, or an applicant has\n notice that information exists that appears material and questionable, that person\n cannot ignore that notice in an effort to avoid his or her duty to disclose.”).\n Materiality controls whether information must be disclosed to the Office, not the\n circumstances under which or the source from which the information is obtained. If\n material, the information must be disclosed to the Office. The duty to disclose material\n information extends to information such individuals are aware of prior to or at the time\n of filing the application or become aware of during the prosecution thereof before the\n application is granted.\n

    ","rendered_text_plain":"All individuals covered by 37 CFR 1.56 (reproduced in MPEP § 2001.01) have a duty to disclose to the U.S. Patent and Trademark Office all material information they are aware of regardless of the source of or how they become aware of the information. See Brasseler, U.S.A. I, L.P. v. Stryker Sales Corp., 267 F.3d 1370, 1383, 60 USPQ2d 1482, 1490 (Fed. Cir. 2001) (“Once an attorney, or an applicant has notice that information exists that appears material and questionable, that person cannot ignore that notice in an effort to avoid his or her duty to disclose.”). Materiality controls whether information must be disclosed to the Office, not the circumstances under which or the source from which the information is obtained. If material, the information must be disclosed to the Office. The duty to disclose material information extends to information such individuals are aware of prior to or at the time of filing the application or become aware of during the prosecution thereof before the application is granted.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195869","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_mos7nx7f"},{"id":"pb_iegaczlf","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_iegaczlf","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    Individuals covered by 37 CFR 1.56 may be or become aware\n of material information from various sources such as, for example, co-workers, trade\n shows, communications from or with competitors, potential infringers, or other third\n parties, related foreign applications (see MPEP § 2001.06(a)), prior or copending\n United States patent applications (see MPEP § 2001.06(b)), related litigation\n and/or post-grant proceedings (see MPEP § 2001.06(c)), preliminary\n examination searches and supporting information related to regulatory review (see\n MPEP §\n 2001.06(e)).\n

    ","rendered_text_plain":"Individuals covered by 37 CFR 1.56 may be or become aware of material information from various sources such as, for example, co-workers, trade shows, communications from or with competitors, potential infringers, or other third parties, related foreign applications (see MPEP § 2001.06(a)), prior or copending United States patent applications (see MPEP § 2001.06(b)), related litigation and/or post-grant proceedings (see MPEP § 2001.06(c)), preliminary examination searches and supporting information related to regulatory review (see MPEP § 2001.06(e)).","provenance":{"source_file":"s2001.html","source_anchor":"d0e195888","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_mos7nx7f"},{"id":"cs_vh55y3vp","node_type":"case","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/cs_vh55y3vp","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"Brasseler, U.S.A. I, L.P. v. Stryker Sales Corp., 267 F.3d 1370 (Fed. Cir. 2001)","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"short_name":"Brasseler, U.S.A. I, L.P. v. Stryker Sales Corp","canonical_citation":"Brasseler, U.S.A. I, L.P. v. Stryker Sales Corp., 267 F.3d 1370, 60 USPQ2d 1482 (Fed. Cir. 2001)","all_citations":["267 F.3d 1370","60 USPQ2d 1482"],"decision_year":2001,"court":"Fed. Cir."},{"id":"pb_necvee6x","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_necvee6x","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    Applicants and other individuals, as set forth in 37 CFR 1.56,\n have a duty to bring to the attention of the Office any material prior art or other\n information cited or brought to their attention in any related foreign application.\n The inference that such prior art or other information is material is especially\n strong where it has been used in rejecting the same or similar claims in the foreign\n application or where it has been identified in some manner as particularly relevant.\n See Gemveto Jewelry Co. v. Lambert Bros., Inc., 542 F. Supp. 933,\n 216 USPQ 976 (S.D. N.Y. 1982) wherein a patent was held invalid or unenforceable\n because patentee’s foreign counsel did not disclose to patentee’s United States\n counsel or to the Office prior art cited by the Dutch Patent Office in connection\n with the patentee’s corresponding Dutch application. The court stated, 542 F. Supp.\n at 943, 216 USPQ at 985:\n

    ","rendered_text_plain":"Applicants and other individuals, as set forth in 37 CFR 1.56, have a duty to bring to the attention of the Office any material prior art or other information cited or brought to their attention in any related foreign application. The inference that such prior art or other information is material is especially strong where it has been used in rejecting the same or similar claims in the foreign application or where it has been identified in some manner as particularly relevant. See Gemveto Jewelry Co. v. Lambert Bros., Inc., 542 F. Supp. 933, 216 USPQ 976 (S.D. N.Y. 1982) wherein a patent was held invalid or unenforceable because patentee’s foreign counsel did not disclose to patentee’s United States counsel or to the Office prior art cited by the Dutch Patent Office in connection with the patentee’s corresponding Dutch application. The court stated, 542 F. Supp. at 943, 216 USPQ at 985:","provenance":{"source_file":"s2001.html","source_anchor":"d0e195904","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_pun5vtgq"},{"id":"cs_uofq6bse","node_type":"case","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/cs_uofq6bse","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"Gemveto Jewelry Co. v. Lambert Bros., Inc., 542 F. Supp. 933 (S.D.N.Y. 1982)","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"short_name":"Gemveto Jewelry Co. v. Lambert Bros., Inc.","canonical_citation":"Gemveto Jewelry Co. v. Lambert Bros., Inc., 542 F. Supp. 933, 216 USPQ 976 (S.D.N.Y. 1982)","all_citations":["542 F. Supp. 933","216 USPQ 976"],"decision_year":1982,"court":"S.D.N.Y."},{"id":"nq_6qsfxz2j","node_type":"narrative_quote","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/nq_6qsfxz2j","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
    \n

    Foreign patent attorneys representing applicants for U.S. patents\n through local correspondent firms surely must be held to the same standards of\n conduct which apply to their American counterparts; a double standard of\n accountability would allow foreign attorneys and their clients to escape\n responsibility for fraud or inequitable conduct merely by withholding from the\n local correspondent information unfavorable to patentability and claiming\n ignorance of United States disclosure requirements.\n

    \n
    ","rendered_text_plain":"Foreign patent attorneys representing applicants for U.S. patents through local correspondent firms surely must be held to the same standards of conduct which apply to their American counterparts; a double standard of accountability would allow foreign attorneys and their clients to escape responsibility for fraud or inequitable conduct merely by withholding from the local correspondent information unfavorable to patentability and claiming ignorance of United States disclosure requirements.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195919","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"source_anchor":"d0e195919","host_section_id":"se_pun5vtgq","source_case_id":"cs_uofq6bse"},{"id":"pb_3bejxofa","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_3bejxofa","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    The individuals covered by 37 CFR 1.56 have a duty to bring\n to the attention of the examiner, or other Office official involved with the\n examination of a particular application, information within their knowledge as to\n other copending United States applications which are “material to patentability” of\n the application in question. This may include providing the identification of pending\n or abandoned applications filed by at least one of the inventors or assigned to the\n same assignee as the current application that disclose similar subject matter that\n are not otherwise identified in the current application. As set forth by the court in\n Armour & Co. v. Swift & Co., 466 F.2d 767, 779, 175\n USPQ 70, 79 (7th Cir. 1972):\n

    ","rendered_text_plain":"The individuals covered by 37 CFR 1.56 have a duty to bring to the attention of the examiner, or other Office official involved with the examination of a particular application, information within their knowledge as to other copending United States applications which are “material to patentability” of the application in question. This may include providing the identification of pending or abandoned applications filed by at least one of the inventors or assigned to the same assignee as the current application that disclose similar subject matter that are not otherwise identified in the current application. As set forth by the court in Armour & Co. v. Swift & Co., 466 F.2d 767, 779, 175 USPQ 70, 79 (7th Cir. 1972):","provenance":{"source_file":"s2001.html","source_anchor":"d0e195935","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_4mzlcy7f"},{"id":"cs_zek5f3le","node_type":"case","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/cs_zek5f3le","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"Armour & Co. v. Swift & Co., 466 F.2d 767 (7th Cir. 1972)","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"short_name":"Armour & Co. v. Swift & Co.","canonical_citation":"Armour & Co. v. Swift & Co., 466 F.2d 767, 175 USPQ 70 (7th Cir. 1972)","all_citations":["466 F.2d 767","175 USPQ 70"],"decision_year":1972,"court":"7th Cir."},{"id":"nq_uax4hxhp","node_type":"narrative_quote","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/nq_uax4hxhp","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"
    \n

    [W]e think that it is unfair to the busy examiner, no matter how\n diligent and well informed he may be, to assume that he retains details of every\n pending file in his mind when he is reviewing a particular application . . . [T]he\n applicant has the burden of presenting the examiner with a complete and accurate\n record to support the allowance of letters patent.\n

    \n
    ","rendered_text_plain":"[W]e think that it is unfair to the busy examiner, no matter how diligent and well informed he may be, to assume that he retains details of every pending file in his mind when he is reviewing a particular application . . . [T]he applicant has the burden of presenting the examiner with a complete and accurate record to support the allowance of letters patent.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195944","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"source_anchor":"d0e195944","host_section_id":"se_4mzlcy7f","source_case_id":"cs_zek5f3le"},{"id":"pb_n2thwjwr","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_n2thwjwr","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    See also MPEP § 2004, paragraph 9.\n

    ","rendered_text_plain":"See also MPEP § 2004, paragraph 9.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195948","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_4mzlcy7f"},{"id":"se_gokqjggw","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_gokqjggw","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-2004","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2004","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2004","section_number":"2004","chapter":"2000","depth":0,"title":"Section 2004","children_ids":[]},{"id":"pb_tpvgz6f3","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_tpvgz6f3","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    Accordingly, the individuals covered by 37 CFR 1.56\n cannot assume that the examiner of a particular application is necessarily aware of\n other applications which are “material to patentability” of the application in\n question, but must instead bring such other applications to the attention of the\n examiner. See Regeneron Pharm., Inc. v. Merus B.V., 144 F. Supp.\n 3d 530, 560 (S.D.N.Y. 2015), and Dayco Prod., Inc. v. Total Containment,\n Inc., 329 F.3d 1358, 1365-69, 66 USPQ2d 1801, 1806-08 (Fed. Cir. 2003).\n For example, if a particular inventor has different applications pending which\n disclose similar subject matter but claim patentably indistinct inventions, the\n existence of other applications must be disclosed to the examiner of each of the\n involved applications. Similarly, the prior art references from one application must\n be made of record in another subsequent application if such prior art references are\n “material to patentability” of the subsequent application. See Dayco\n Prod., 329 F.3d at 1369, 66 USPQ2d at 1808.\n

    ","rendered_text_plain":"Accordingly, the individuals covered by 37 CFR 1.56 cannot assume that the examiner of a particular application is necessarily aware of other applications which are “material to patentability” of the application in question, but must instead bring such other applications to the attention of the examiner. See Regeneron Pharm., Inc. v. Merus B.V., 144 F. Supp. 3d 530, 560 (S.D.N.Y. 2015), and Dayco Prod., Inc. v. Total Containment, Inc., 329 F.3d 1358, 1365-69, 66 USPQ2d 1801, 1806-08 (Fed. Cir. 2003). For example, if a particular inventor has different applications pending which disclose similar subject matter but claim patentably indistinct inventions, the existence of other applications must be disclosed to the examiner of each of the involved applications. Similarly, the prior art references from one application must be made of record in another subsequent application if such prior art references are “material to patentability” of the subsequent application. See Dayco Prod., 329 F.3d at 1369, 66 USPQ2d at 1808.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195954","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_4mzlcy7f"},{"id":"cs_tsdgh4lv","node_type":"case","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/cs_tsdgh4lv","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"Regeneron Pharm., Inc. v. Merus B.V., 144 F. Supp. 3d 530 (S.D.N.Y. 2015)","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"short_name":"Regeneron Pharm., Inc. v. Merus B.V.","canonical_citation":"Regeneron Pharm., Inc. v. Merus B.V., 144 F. Supp. 3d 530 (S.D.N.Y. 2015)","all_citations":["144 F. Supp. 3d 530"],"decision_year":2015,"court":"S.D.N.Y."},{"id":"cs_cvx4zb3m","node_type":"case","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/cs_cvx4zb3m","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"Dayco Prod., Inc. v. Total Containment, Inc., 329 F.3d 1358 (Fed. Cir. 2003)","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"short_name":"Dayco Prod., Inc. v. Total Containment, Inc.","canonical_citation":"Dayco Prod., Inc. v. Total Containment, Inc., 329 F.3d 1358, 66 USPQ2d 1801 (Fed. Cir. 2003)","all_citations":["329 F.3d 1358","66 USPQ2d 1801"],"decision_year":2003,"court":"Fed. Cir."},{"id":"pb_bli7rsgm","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_bli7rsgm","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    If the application under examination is identified as a\n continuation, divisional, or continuation-in-part of an earlier application, the\n examiner will consider the prior art properly cited in the earlier application. See\n MPEP §\n 609 and MPEP § 719.05, subsection (II)(A),\n example J. The examiner must indicate in the first Office action whether the prior\n art in a related earlier application has been reviewed. Accordingly, no separate\n citation of the same prior art need be made in the later application, unless\n applicant wants a listing of the prior art printed on the face of the patent.\n

    ","rendered_text_plain":"If the application under examination is identified as a continuation, divisional, or continuation-in-part of an earlier application, the examiner will consider the prior art properly cited in the earlier application. See MPEP § 609 and MPEP § 719.05, subsection (II)(A), example J. The examiner must indicate in the first Office action whether the prior art in a related earlier application has been reviewed. Accordingly, no separate citation of the same prior art need be made in the later application, unless applicant wants a listing of the prior art printed on the face of the patent.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195973","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_4mzlcy7f"},{"id":"se_nqrayyqh","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_nqrayyqh","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-719","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_719","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_719","section_number":"719","chapter":"700","depth":0,"title":"Section 719","children_ids":[]},{"id":"pb_yziethnb","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_yziethnb","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    The America Invents Act (AIA) added trial proceedings to be\n conducted by the Patent Trial and Appeal Board (PTAB) including inter\n partes review proceedings, post-grant review, covered business method\n reviews, and derivation. In many instances, these trial proceedings yield information\n that may be considered material to pending related patent applications. Where the\n subject matter for which a patent is being sought is or has been involved in\n litigation and/or a trial proceeding, or the litigation and/or trial proceeding\n yields information material to currently pending applications, the existence of such\n litigation and any other material information arising therefrom must be brought to\n the attention of the examiner or other appropriate official at the U.S. Patent and\n Trademark Office. In particular, material information that is raised in trial\n proceedings that is relevant to related applications undergoing examination should be\n submitted on an Information Disclosure Statement for the examiner’s consideration.\n Examples of such material information include evidence of possible prior public use\n or sales, questions of inventorship, prior art, allegations of “fraud,” “inequitable\n conduct,” and “violation of duty of disclosure.” Another example of such material\n information is any assertion that is made during litigation and/or trial proceeding\n which is contradictory to assertions made to the examiner. Environ Prods.,\n Inc. v. Total Containment, Inc., 43 USPQ2d 1288, 1291 (E.D. Pa. 1997).\n Such information might arise during litigation and/or trial proceeding in, for\n example, pleadings, admissions, discovery including interrogatories, depositions, and\n other documents and testimony.\n

    ","rendered_text_plain":"The America Invents Act (AIA) added trial proceedings to be conducted by the Patent Trial and Appeal Board (PTAB) including inter partes review proceedings, post-grant review, covered business method reviews, and derivation. In many instances, these trial proceedings yield information that may be considered material to pending related patent applications. Where the subject matter for which a patent is being sought is or has been involved in litigation and/or a trial proceeding, or the litigation and/or trial proceeding yields information material to currently pending applications, the existence of such litigation and any other material information arising therefrom must be brought to the attention of the examiner or other appropriate official at the U.S. Patent and Trademark Office. In particular, material information that is raised in trial proceedings that is relevant to related applications undergoing examination should be submitted on an Information Disclosure Statement for the examiner’s consideration. Examples of such material information include evidence of possible prior public use or sales, questions of inventorship, prior art, allegations of “fraud,” “inequitable conduct,” and “violation of duty of disclosure.” Another example of such material information is any assertion that is made during litigation and/or trial proceeding which is contradictory to assertions made to the examiner. Environ Prods., Inc. v. Total Containment, Inc., 43 USPQ2d 1288, 1291 (E.D. Pa. 1997). Such information might arise during litigation and/or trial proceeding in, for example, pleadings, admissions, discovery including interrogatories, depositions, and other documents and testimony.","provenance":{"source_file":"s2001.html","source_anchor":"d0e195994","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_jeakewet"},{"id":"cs_u2l34bbj","node_type":"case","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/cs_u2l34bbj","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"Environ Prods., Inc. v. Total Containment, Inc., 43 USPQ2d 1288 (E.D. Pa. 1997)","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"short_name":"Environ Prods., Inc. v. Total Containment, Inc.","canonical_citation":"Environ Prods., Inc. v. Total Containment, Inc., 43 USPQ2d 1288 (E.D. Pa. 1997)","all_citations":["43 USPQ2d 1288"],"decision_year":1997,"court":"E.D. Pa."},{"id":"pb_rrgoy4mp","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_rrgoy4mp","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    Where a patent for which reissue is being sought is, or has been,\n involved in litigation and/or trial proceeding which raised a question material to\n examination of the reissue application, such as the validity of the patent, or any\n allegation of “fraud,” “inequitable conduct,” or “violation of duty of disclosure,”\n the existence of such litigation and/or trial proceeding must be brought to the\n attention of the examiner by the applicant at the time of, or shortly after, filing\n the application. Such information can be disclosed either in the reissue oath or\n declaration, or in a separate paper, preferably accompanying the application, as\n filed. Litigation and/or trial proceedings that begin after filing of the reissue\n application should be promptly brought to the attention of the Office. The details\n and documents from the litigation and/or trial proceedings, insofar as they are\n “material to patentability” of the reissue application as defined in\n 37 CFR\n 1.56, should accompany the application as filed, or be\n submitted as promptly thereafter as possible. See Critikon, Inc. v. Becton\n Dickinson Vascular Access, Inc., 120 F.3d 1253, 1258-59, 43 USPQ2d 1666,\n 1670-71 (Fed. Cir. 1997) (patent held unenforceable due to inequitable conduct based\n on patentee's failure to disclose a relevant reference and for failing to disclose\n ongoing litigation).\n

    ","rendered_text_plain":"Where a patent for which reissue is being sought is, or has been, involved in litigation and/or trial proceeding which raised a question material to examination of the reissue application, such as the validity of the patent, or any allegation of “fraud,” “inequitable conduct,” or “violation of duty of disclosure,” the existence of such litigation and/or trial proceeding must be brought to the attention of the examiner by the applicant at the time of, or shortly after, filing the application. Such information can be disclosed either in the reissue oath or declaration, or in a separate paper, preferably accompanying the application, as filed. Litigation and/or trial proceedings that begin after filing of the reissue application should be promptly brought to the attention of the Office. The details and documents from the litigation and/or trial proceedings, insofar as they are “material to patentability” of the reissue application as defined in 37 CFR 1.56, should accompany the application as filed, or be submitted as promptly thereafter as possible. See Critikon, Inc. v. Becton Dickinson Vascular Access, Inc., 120 F.3d 1253, 1258-59, 43 USPQ2d 1666, 1670-71 (Fed. Cir. 1997) (patent held unenforceable due to inequitable conduct based on patentee's failure to disclose a relevant reference and for failing to disclose ongoing litigation).","provenance":{"source_file":"s2001.html","source_anchor":"d0e196000","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_jeakewet"},{"id":"cs_53zck3at","node_type":"case","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/cs_53zck3at","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"Critikon, Inc. v. Becton Dickinson Vascular Access, Inc., 120 F.3d 1253 (Fed. Cir. 1997)","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"short_name":"Critikon, Inc. v. Becton Dickinson Vascular Access, Inc.","canonical_citation":"Critikon, Inc. v. Becton Dickinson Vascular Access, Inc., 120 F.3d 1253, 43 USPQ2d 1666 (Fed. Cir. 1997)","all_citations":["120 F.3d 1253","43 USPQ2d 1666"],"decision_year":1997,"court":"Fed. Cir."},{"id":"pb_kj6y7dzb","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_kj6y7dzb","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    For example, the defenses raised against validity of the patent, or\n charges of “fraud” or “inequitable conduct” in the litigation, would normally be\n “material to the examination” of the reissue application. It would, in most\n situations, be appropriate to bring such defenses to the attention of the Office by\n filing in the reissue application a copy of the court papers raising such defenses.\n At a minimum, the applicant should call the attention of the Office to the\n litigation, the existence and the nature of any allegations relating to validity\n and/or “fraud,” or “inequitable conduct” relating to the original patent, and the\n nature of litigation materials relating to these issues. Enough information should be\n submitted to clearly inform the Office of the nature of these issues so that the\n Office can intelligently evaluate the need for asking for further materials in the\n litigation. See MPEP §\n 1442.04.\n

    ","rendered_text_plain":"For example, the defenses raised against validity of the patent, or charges of “fraud” or “inequitable conduct” in the litigation, would normally be “material to the examination” of the reissue application. It would, in most situations, be appropriate to bring such defenses to the attention of the Office by filing in the reissue application a copy of the court papers raising such defenses. At a minimum, the applicant should call the attention of the Office to the litigation, the existence and the nature of any allegations relating to validity and/or “fraud,” or “inequitable conduct” relating to the original patent, and the nature of litigation materials relating to these issues. Enough information should be submitted to clearly inform the Office of the nature of these issues so that the Office can intelligently evaluate the need for asking for further materials in the litigation. See MPEP § 1442.04.","provenance":{"source_file":"s2001.html","source_anchor":"d0e196009","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_jeakewet"},{"id":"se_ftjp5bvc","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_ftjp5bvc","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-1442","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_1442","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_1442","section_number":"1442","chapter":"1400","depth":0,"title":"Section 1442","children_ids":[]},{"id":"pb_bjsng7pm","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_bjsng7pm","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    If litigation papers of a live litigation relating to a pending\n reissue application are filed with the Office, the Solicitor’s Office should be\n notified of the filing of the litigation papers in the application file. If the\n litigation is not live, the litigation papers are processed by the Technology Center\n assigned the reissue application.\n

    ","rendered_text_plain":"If litigation papers of a live litigation relating to a pending reissue application are filed with the Office, the Solicitor’s Office should be notified of the filing of the litigation papers in the application file. If the litigation is not live, the litigation papers are processed by the Technology Center assigned the reissue application.","provenance":{"source_file":"s2001.html","source_anchor":"d0e196015","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_jeakewet"},{"id":"pb_glhty7ys","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_glhty7ys","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    Where claims are copied or substantially copied from a patent,\n 37 CFR\n 41.202(a) requires the applicant, at the time he or she\n presents the claim(s), to identify the patent and the numbers of the patent claims.\n Clearly, the information required by 37 CFR 41.202(a) as to the source\n of copied claims is material information under 37 CFR 1.56 and failure to inform\n the USPTO of such information may violate the duty of disclosure.\n

    ","rendered_text_plain":"Where claims are copied or substantially copied from a patent, 37 CFR 41.202(a) requires the applicant, at the time he or she presents the claim(s), to identify the patent and the numbers of the patent claims. Clearly, the information required by 37 CFR 41.202(a) as to the source of copied claims is material information under 37 CFR 1.56 and failure to inform the USPTO of such information may violate the duty of disclosure.","provenance":{"source_file":"s2001.html","source_anchor":"d0e196028","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_mqkgz2vr"},{"id":"pb_3hhbvhrz","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_3hhbvhrz","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    Where relevant documentation is submitted to a\n regulatory review body, such as the U.S. Food & Drug Administration (FDA), and is\n material to any pending patent application or reexamination proceeding, such\n documentation should be submitted for Office review. While the considerations made by\n the FDA for approving clinical trials are different from those made by the USPTO in\n determining whether a claim is patentable, submissions, particularly any assertion\n that is made which is contradictory to assertions made to the examiner, may be\n material to ongoing patent proceedings. Belcher Pharmaceuticals, LLC v.\n Hospira, Inc., 11 F.4th 1345, 1353-54, 2021 USPQ2d 909 (Fed. Cir. 2021).\n See also MPEP §\n 2164.05. Duty of disclosure may require that if the actual\n filing date of an application is after the date of the applicant’s date of marketing\n approval by FDA, and the applicant intends to list any resulting patent in the orange\n book for that product, informing the USPTO during examination of the application of\n that intent and applicant should consider providing the Paragraph IV “factual and\n legal basis” notice to USPTO. \n

    ","rendered_text_plain":"Where relevant documentation is submitted to a regulatory review body, such as the U.S. Food & Drug Administration (FDA), and is material to any pending patent application or reexamination proceeding, such documentation should be submitted for Office review. While the considerations made by the FDA for approving clinical trials are different from those made by the USPTO in determining whether a claim is patentable, submissions, particularly any assertion that is made which is contradictory to assertions made to the examiner, may be material to ongoing patent proceedings. Belcher Pharmaceuticals, LLC v. Hospira, Inc., 11 F.4th 1345, 1353-54, 2021 USPQ2d 909 (Fed. Cir. 2021). See also MPEP § 2164.05. Duty of disclosure may require that if the actual filing date of an application is after the date of the applicant’s date of marketing approval by FDA, and the applicant intends to list any resulting patent in the orange book for that product, informing the USPTO during examination of the application of that intent and applicant should consider providing the Paragraph IV “factual and legal basis” notice to USPTO.","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_337d9_22f81_de","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_dw4peeun"},{"id":"se_szisyzcx","node_type":"section","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/se_szisyzcx","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"stub-2164","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2164","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2164","section_number":"2164","chapter":"2100","depth":0,"title":"Section 2164","children_ids":[]},{"id":"cs_murlb6zx","node_type":"case","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/cs_murlb6zx","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"Belcher Pharmaceuticals, LLC v. Hospira, Inc., 11 F.4th 1345 (Fed. Cir. 2021)","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"short_name":"Belcher Pharmaceuticals, LLC v. Hospira, Inc.","canonical_citation":"Belcher Pharmaceuticals, LLC v. Hospira, Inc., 11 F.4th 1345, 2021 USPQ2d 909 (Fed. Cir. 2021)","all_citations":["11 F.4th 1345","2021 USPQ2d 909"],"decision_year":2021,"court":"Fed. Cir."},{"id":"pb_peghdvd3","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/pb_peghdvd3","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"

    Accordingly, each party presenting a paper to the\n USPTO, whether a practitioner or non-practitioner, has a duty to perform an inquiry\n that is reasonable under the circumstances. This reasonable inquiry may comprise\n reviewing documents that are submitted to or received from other Government agencies,\n including the FDA. If any reviewed document is material to the patentability of a\n pending matter before the Office, such as a patent application (including a reissue\n application), or a reexamination proceeding, the party has a duty to submit the\n information to the USPTO. 37 CFR 1.56, 1.555, and\n 11.18(b)(2). A duty of reasonable inquiry may exist based on\n circumstances known to the party presenting the paper to the USPTO. Failing to\n inquire when the circumstances warrant it could result in sanctions or other action\n under 37 CFR\n 11.18(c), which may include: (1) striking the offending paper;\n (2) referring a practitioner’s conduct to the Director of Enrollment and Discipline\n for appropriate action; (3) precluding a party or practitioner from submitting a\n paper, or presenting or contesting an issue; (4) affecting the weight given to the\n offending paper; or (5) terminating the proceedings in the Office. See, e.g.,\n In re Hao, Proceeding No. D2021-14 (USPTO Apr. 27, 2022)\n (involving disciplinary sanctions predicated on non-compliance with 37 CFR 11.18).\n See also MPEP § 2015.\n

    ","rendered_text_plain":"Accordingly, each party presenting a paper to the USPTO, whether a practitioner or non-practitioner, has a duty to perform an inquiry that is reasonable under the circumstances. This reasonable inquiry may comprise reviewing documents that are submitted to or received from other Government agencies, including the FDA. If any reviewed document is material to the patentability of a pending matter before the Office, such as a patent application (including a reissue application), or a reexamination proceeding, the party has a duty to submit the information to the USPTO. 37 CFR 1.56, 1.555, and 11.18(b)(2). A duty of reasonable inquiry may exist based on circumstances known to the party presenting the paper to the USPTO. Failing to inquire when the circumstances warrant it could result in sanctions or other action under 37 CFR 11.18(c), which may include: (1) striking the offending paper; (2) referring a practitioner’s conduct to the Director of Enrollment and Discipline for appropriate action; (3) precluding a party or practitioner from submitting a paper, or presenting or contesting an issue; (4) affecting the weight given to the offending paper; or (5) terminating the proceedings in the Office. See, e.g., In re Hao, Proceeding No. D2021-14 (USPTO Apr. 27, 2022) (involving disciplinary sanctions predicated on non-compliance with 37 CFR 11.18). See also MPEP § 2015.","provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_1960f_ee","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"kind":"narrative","host_section_id":"se_dw4peeun"},{"id":"cs_rr6aj5aq","node_type":"case","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/cs_rr6aj5aq","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"In re Hao, Proceeding No. D2021-14 (USPTO Apr. 27, 2022)","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"short_name":"In re Hao","canonical_citation":"In re Hao, Proceeding No. D2021-14 (USPTO Apr. 27, 2022)","all_citations":["Proceeding No. D2021-14"],"decision_year":2022,"court":"USPTO"},{"id":"st_pakwvrk3","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_pakwvrk3","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","subsection_path":[],"canonical_citation":"37 CFR 1.56"},{"id":"st_3rgbpbte","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_3rgbpbte","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","subsection_path":["c"],"canonical_citation":"37 CFR 1.56(c)"},{"id":"st_hwjf4hwo","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_hwjf4hwo","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.555","subsection_path":["a"],"canonical_citation":"37 CFR 1.555(a)"},{"id":"st_p3mbtyeh","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_p3mbtyeh","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","subsection_path":["a"],"canonical_citation":"37 CFR 1.56(a)"},{"id":"st_jts3jwo2","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_jts3jwo2","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.555","subsection_path":[],"canonical_citation":"37 CFR 1.555"},{"id":"st_odokmrtz","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_odokmrtz","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","subsection_path":["b","2"],"canonical_citation":"37 CFR 1.56(b)(2)"},{"id":"st_myxjyemn","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_myxjyemn","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.501","subsection_path":[],"canonical_citation":"37 CFR 1.501"},{"id":"st_hm3nzyfw","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_hm3nzyfw","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.290","subsection_path":[],"canonical_citation":"37 CFR 1.290"},{"id":"st_3itgecqm","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_3itgecqm","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.291","subsection_path":[],"canonical_citation":"37 CFR 1.291"},{"id":"st_hylu5avb","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_hylu5avb","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","subsection_path":["b"],"canonical_citation":"37 CFR 1.56(b)"},{"id":"st_lpuifvgb","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_lpuifvgb","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.105","subsection_path":["a","1"],"canonical_citation":"37 CFR 1.105(a)(1)"},{"id":"st_3fkq35wa","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_3fkq35wa","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.105","subsection_path":[],"canonical_citation":"37 CFR 1.105"},{"id":"st_vwrlxzfk","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_vwrlxzfk","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.291","subsection_path":["a"],"canonical_citation":"37 CFR 1.291(a)"},{"id":"st_xnluj52p","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_xnluj52p","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.97","subsection_path":["d"],"canonical_citation":"37 CFR 1.97(d)"},{"id":"st_t63cnbye","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_t63cnbye","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.313","subsection_path":["c","1"],"canonical_citation":"37 CFR 1.313(c)(1)"},{"id":"st_xa7emtaq","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_xa7emtaq","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.313","subsection_path":["c","3"],"canonical_citation":"37 CFR 1.313(c)(3)"},{"id":"st_xaagzx5p","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_xaagzx5p","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.114","subsection_path":[],"canonical_citation":"37 CFR 1.114"},{"id":"st_4erpxvog","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_4erpxvog","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.313","subsection_path":["a"],"canonical_citation":"37 CFR 1.313(a)"},{"id":"st_p6pxlcjt","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_p6pxlcjt","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.313","subsection_path":["c","2"],"canonical_citation":"37 CFR 1.313(c)(2)"},{"id":"st_e265q4i4","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_e265q4i4","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","subsection_path":["e"],"canonical_citation":"37 CFR 1.56(e)"},{"id":"st_va54qzfn","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_va54qzfn","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.97","subsection_path":[],"canonical_citation":"37 CFR 1.97"},{"id":"st_hd4635gd","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_hd4635gd","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.98","subsection_path":[],"canonical_citation":"37 CFR 1.98"},{"id":"st_gmbrbe3i","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_gmbrbe3i","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_usc","authority_title_num":"35","authority_section_num":"257","subsection_path":[],"canonical_citation":"35 U.S.C. 257"},{"id":"st_i4e73zok","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_i4e73zok","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.625","subsection_path":["d","4"],"canonical_citation":"37 CFR 1.625(d)(4)"},{"id":"st_a7qru65a","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_a7qru65a","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"1.56","subsection_path":["b","1"],"canonical_citation":"37 CFR 1.56(b)(1)"},{"id":"st_ktpxrf7g","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_ktpxrf7g","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"41.202","subsection_path":["a"],"canonical_citation":"37 CFR 41.202(a)"},{"id":"st_oevyffmr","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_oevyffmr","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"11.18","subsection_path":["b","2"],"canonical_citation":"37 CFR 11.18(b)(2)"},{"id":"st_vj6qwdrc","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_vj6qwdrc","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"11.18","subsection_path":["c"],"canonical_citation":"37 CFR 11.18(c)"},{"id":"st_tvsspi4a","node_type":"statute","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/st_tvsspi4a","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"authority":"us_cfr","authority_title_num":"37","authority_section_num":"11.18","subsection_path":[],"canonical_citation":"37 CFR 11.18"},{"id":"cs_hjvwc6cb","node_type":"case","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/cs_hjvwc6cb","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"In re Tendler, Proceeding No. D2013-17 (USPTO Jan. 1, 2014)","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"short_name":"In re Tendler","canonical_citation":"In re Tendler, Proceeding No. D2013-17 (USPTO Jan. 1, 2014)","all_citations":["Proceeding No. D2013-17"],"decision_year":2014,"court":"USPTO"},{"id":"cs_2fxxg5no","node_type":"case","corpus_id":"mpep-e9r01-2024-html","opaque_url":"https://mpep.io/n/cs_2fxxg5no","effective_range":{"start_revision":"R-08.2017","end_revision":null},"rendered_text_html":"","rendered_text_plain":"Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc., 326 F.3d 1226 (Fed. Cir. 2003)","provenance":{"source_file":"s2001.html","source_anchor":"","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"},"short_name":"Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc.","canonical_citation":"Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc., 326 F.3d 1226, 66 USPQ2d 1481 (Fed. Cir. 2003)","all_citations":["326 F.3d 1226","66 USPQ2d 1481"],"decision_year":2003,"court":"Fed. Cir."}],"edges":[{"id":"e_gywnto7c","edge_type":"cites-statute","source_id":"pb_lciirwhl","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":0,"end":11}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195534","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_bhvn5fes","edge_type":"cites-statute","source_id":"pb_hnhcsilf","target_id":"st_3rgbpbte","properties":{"citation_text":"37 CFR 1.56(c)","specificity":"subsection","source_offset":{"start":263,"end":277}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195568","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_rukk5zcy","edge_type":"cites-statute","source_id":"pb_hnhcsilf","target_id":"st_hwjf4hwo","properties":{"citation_text":"37 CFR 1.555(a)","specificity":"subsection","source_offset":{"start":282,"end":290}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195568","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_6qm6rqhx","edge_type":"cites-statute","source_id":"pb_hnhcsilf","target_id":"st_hwjf4hwo","properties":{"citation_text":"37 CFR 1.555(a)","specificity":"subsection","source_offset":{"start":1115,"end":1130}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195568","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_hbg2cqxy","edge_type":"cites-statute","source_id":"pb_vzxdktxo","target_id":"st_p3mbtyeh","properties":{"citation_text":"37 CFR 1.56(a)","specificity":"subsection","source_offset":{"start":0,"end":14}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195578","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_l5g7jbfl","edge_type":"cites-statute","source_id":"pb_5fkbbah4","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":16,"end":27}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195618","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_bivesy6t","edge_type":"cites-statute","source_id":"pb_5fkbbah4","target_id":"st_jts3jwo2","properties":{"citation_text":"37 CFR 1.555","specificity":"section","source_offset":{"start":33,"end":45}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195618","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_u6jq63ds","edge_type":"cites-statute","source_id":"pb_5fkbbah4","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":169,"end":180}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195618","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_fkftwtbs","edge_type":"cites-statute","source_id":"pb_42ureqy5","target_id":"st_odokmrtz","properties":{"citation_text":"37 CFR 1.56(b)(2)","specificity":"paragraph","source_offset":{"start":761,"end":778}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18c9a_fe","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_mxt5qvq6","edge_type":"cites-statute","source_id":"pb_42ureqy5","target_id":"st_myxjyemn","properties":{"citation_text":"37 CFR 1.501","specificity":"section","source_offset":{"start":1009,"end":1021}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18c9a_fe","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_pt24y6dx","edge_type":"cites-statute","source_id":"pb_42ureqy5","target_id":"st_hm3nzyfw","properties":{"citation_text":"37 CFR 1.290","specificity":"section","source_offset":{"start":1156,"end":1168}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18c9a_fe","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_76thh3hb","edge_type":"cites-statute","source_id":"pb_42ureqy5","target_id":"st_3itgecqm","properties":{"citation_text":"37 CFR 1.291","specificity":"section","source_offset":{"start":1188,"end":1200}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18c9a_fe","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_yvyyzao2","edge_type":"cites-statute","source_id":"pb_42ureqy5","target_id":"st_myxjyemn","properties":{"citation_text":"37 CFR 1.501","specificity":"section","source_offset":{"start":1319,"end":1331}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18c9a_fe","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_qsfhdl47","edge_type":"cross-references","source_id":"pb_42ureqy5","target_id":"se_7xa3kxa7","properties":{"link_text":"MPEP § 2016","target_anchor":"d0e196894"},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18c9a_fe","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_neqj245g","edge_type":"cites-statute","source_id":"pb_t5drfrlx","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":33,"end":44}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195646","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_oaetezmh","edge_type":"cites-statute","source_id":"pb_wltefpvy","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":0,"end":11}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195652","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_znlh6m35","edge_type":"cites-statute","source_id":"pb_vvpsvooy","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":34,"end":45}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195657","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_4t3jp54l","edge_type":"cites-statute","source_id":"pb_vvpsvooy","target_id":"st_hylu5avb","properties":{"citation_text":"37 CFR 1.56(b)","specificity":"subsection","source_offset":{"start":202,"end":216}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195657","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_h4limwwe","edge_type":"cross-references","source_id":"pb_vvpsvooy","target_id":"se_rlnwhhop","properties":{"link_text":"MPEP § 2001.05","target_anchor":"d0e195810"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195657","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_nnxzihyi","edge_type":"cites-statute","source_id":"pb_vvpsvooy","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":316,"end":327}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195657","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_x4pgw2g2","edge_type":"cites-statute","source_id":"pb_shn7jew4","target_id":"st_lpuifvgb","properties":{"citation_text":"37 CFR 1.105(a)(1)","specificity":"paragraph","source_offset":{"start":235,"end":253}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18eda_145","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_tjpkeyqy","edge_type":"cites-statute","source_id":"pb_shn7jew4","target_id":"st_3fkq35wa","properties":{"citation_text":"37 CFR 1.105","specificity":"section","source_offset":{"start":345,"end":357}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18eda_145","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_wp3ex2o7","edge_type":"cites-statute","source_id":"pb_shn7jew4","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":411,"end":422}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18eda_145","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_mcfw22nu","edge_type":"cross-references","source_id":"pb_shn7jew4","target_id":"se_n3cepdog","properties":{"link_text":"MPEP § 704.12(a)","target_anchor":"d0e56242"},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18eda_145","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_z6234ocg","edge_type":"cites-statute","source_id":"pb_shn7jew4","target_id":"st_3rgbpbte","properties":{"citation_text":"37 CFR 1.56(c)","specificity":"subsection","source_offset":{"start":650,"end":664}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18eda_145","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_46z7654g","edge_type":"cross-references","source_id":"pb_shn7jew4","target_id":"se_vj6nqkne","properties":{"link_text":"MPEP § 2015","target_anchor":"ch2000_d22347_2a6eb_38b"},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18eda_145","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_3w5dnrcp","edge_type":"cites-statute","source_id":"pb_otisysyv","target_id":"st_vwrlxzfk","properties":{"citation_text":"37 CFR 1.291(a)","specificity":"subsection","source_offset":{"start":121,"end":136}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195685","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_aa7bnvxx","edge_type":"cross-references","source_id":"pb_otisysyv","target_id":"se_m3lq2fhz","properties":{"link_text":"MPEP § 1901.02","target_anchor":"d0e193964"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195685","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_n4wlfxqk","edge_type":"cites-statute","source_id":"pb_otisysyv","target_id":"st_p3mbtyeh","properties":{"citation_text":"37 CFR 1.56(a)","specificity":"subsection","source_offset":{"start":159,"end":173}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195685","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_utrequdv","edge_type":"cites-statute","source_id":"pb_lm6z5iv4","target_id":"st_p3mbtyeh","properties":{"citation_text":"37 CFR 1.56(a)","specificity":"subsection","source_offset":{"start":0,"end":14}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195706","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_bv43mypc","edge_type":"cites-statute","source_id":"pb_lm6z5iv4","target_id":"st_xnluj52p","properties":{"citation_text":"37 CFR 1.97(d)","specificity":"subsection","source_offset":{"start":382,"end":396}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195706","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_oxfkcpgd","edge_type":"cross-references","source_id":"pb_lm6z5iv4","target_id":"se_ql6l6rdc","properties":{"link_text":"MPEP § 609.04(b), subsection III","target_anchor":"d0e53830"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195706","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_5ym2zsay","edge_type":"cites-statute","source_id":"li_5fis55ud","target_id":"st_t63cnbye","properties":{"citation_text":"37 CFR 1.313(c)(1)","specificity":"paragraph","source_offset":{"start":49,"end":67}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195718","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_7v7a5pmb","edge_type":"cites-statute","source_id":"li_ovehpgog","target_id":"st_xa7emtaq","properties":{"citation_text":"37 CFR 1.313(c)(3)","specificity":"paragraph","source_offset":{"start":118,"end":136}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195725","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_deui7jcz","edge_type":"cites-statute","source_id":"li_ow2kpjlb","target_id":"st_xaagzx5p","properties":{"citation_text":"37 CFR 1.114","specificity":"section","source_offset":{"start":73,"end":85}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195732","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_arrkgk4l","edge_type":"cites-statute","source_id":"li_ow2kpjlb","target_id":"st_4erpxvog","properties":{"citation_text":"37 CFR 1.313(a)","specificity":"subsection","source_offset":{"start":87,"end":102}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195732","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_x2u5i5zr","edge_type":"cites-statute","source_id":"li_ow2kpjlb","target_id":"st_p6pxlcjt","properties":{"citation_text":"37 CFR 1.313(c)(2)","specificity":"paragraph","source_offset":{"start":107,"end":113}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195732","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_th5e4rd5","edge_type":"cross-references","source_id":"li_ow2kpjlb","target_id":"se_wfpxd3yo","properties":{"link_text":"MPEP § 706.07(h)","target_anchor":"d0e70778"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195732","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_ebmy2e2h","edge_type":"cross-references","source_id":"pb_5tavpib3","target_id":"se_mujtnnwg","properties":{"link_text":"MPEP § 1308","target_anchor":"d0e133618"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195745","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_wltmypgp","edge_type":"cites-statute","source_id":"pb_gyopr5lp","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":62,"end":73}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195751","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_mt3kptld","edge_type":"cites-statute","source_id":"pb_gyopr5lp","target_id":"st_e265q4i4","properties":{"citation_text":"37 CFR 1.56(e)","specificity":"subsection","source_offset":{"start":333,"end":347}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195751","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_gkkyabsr","edge_type":"cites-statute","source_id":"pb_raw3c6uh","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":0,"end":11}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195763","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_qiqxacne","edge_type":"cites-statute","source_id":"pb_raw3c6uh","target_id":"st_va54qzfn","properties":{"citation_text":"37 CFR 1.97","specificity":"section","source_offset":{"start":128,"end":139}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195763","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_adllsrf3","edge_type":"cites-statute","source_id":"pb_raw3c6uh","target_id":"st_hd4635gd","properties":{"citation_text":"37 CFR 1.98","specificity":"section","source_offset":{"start":144,"end":148}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195763","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_v5vfrmn3","edge_type":"cross-references","source_id":"pb_raw3c6uh","target_id":"se_ql6l6rdc","properties":{"link_text":"MPEP § 609","target_anchor":"d0e52594"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195763","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_ngv67nfe","edge_type":"cross-references","source_id":"pb_raw3c6uh","target_id":"se_siblb6xz","properties":{"link_text":"MPEP § 2242","target_anchor":"d0e225368"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195763","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_gr75dtoi","edge_type":"cross-references","source_id":"pb_raw3c6uh","target_id":"se_32rnaq3e","properties":{"link_text":"MPEP § 2258.01","target_anchor":"d0e230030"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195763","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_i7ln5vet","edge_type":"cites-statute","source_id":"pb_mymzesyu","target_id":"st_jts3jwo2","properties":{"citation_text":"37 CFR 1.555","specificity":"section","source_offset":{"start":0,"end":12}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_298db_200b3_1fb","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_3dxeapis","edge_type":"cross-references","source_id":"pb_mymzesyu","target_id":"se_mcwwdtbj","properties":{"link_text":"MPEP § 2280","target_anchor":"d0e234039"},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_298db_200b3_1fb","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_x4iuzuar","edge_type":"cross-references","source_id":"pb_mymzesyu","target_id":"se_5ssvsirp","properties":{"link_text":"MPEP § 2684","target_anchor":"d0e267936"},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_298db_200b3_1fb","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_6u4p334s","edge_type":"cites-statute","source_id":"pb_mymzesyu","target_id":"st_gmbrbe3i","properties":{"citation_text":"35 U.S.C. 257","specificity":"section","source_offset":{"start":285,"end":298}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_298db_200b3_1fb","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_mmvfbv26","edge_type":"cites-statute","source_id":"pb_mymzesyu","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":352,"end":363}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_298db_200b3_1fb","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_7jupnrcv","edge_type":"cites-statute","source_id":"pb_mymzesyu","target_id":"st_i4e73zok","properties":{"citation_text":"37 CFR 1.625(d)(4)","specificity":"paragraph","source_offset":{"start":369,"end":387}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_298db_200b3_1fb","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_rvrotmk4","edge_type":"cross-references","source_id":"pb_mymzesyu","target_id":"se_ossiva7v","properties":{"link_text":"MPEP § 2820","target_anchor":"ch2800_d1ff00_2731c_345"},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_298db_200b3_1fb","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_575lqqad","edge_type":"cites-statute","source_id":"pb_vgvxkuf7","target_id":"st_a7qru65a","properties":{"citation_text":"37 CFR 1.56(b)(1)","specificity":"paragraph","source_offset":{"start":85,"end":102}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195856","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_gsgleypd","edge_type":"cites-statute","source_id":"pb_vgvxkuf7","target_id":"st_odokmrtz","properties":{"citation_text":"37 CFR 1.56(b)(2)","specificity":"paragraph","source_offset":{"start":106,"end":109}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195856","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_s37ryelm","edge_type":"cites-statute","source_id":"pb_vgvxkuf7","target_id":"st_hylu5avb","properties":{"citation_text":"37 CFR 1.56(b)","specificity":"subsection","source_offset":{"start":708,"end":722}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195856","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_uottigfr","edge_type":"cites-statute","source_id":"pb_mawk3sgk","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":27,"end":38}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195869","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_wpbwmd6h","edge_type":"cross-references","source_id":"pb_mawk3sgk","target_id":"se_5hb4c2hn","properties":{"link_text":"MPEP § 2001.01","target_anchor":"d0e195539"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195869","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_3xtb46xv","edge_type":"cites-statute","source_id":"pb_iegaczlf","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":23,"end":34}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195888","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_4rdhj6kw","edge_type":"cross-references","source_id":"pb_iegaczlf","target_id":"se_pun5vtgq","properties":{"link_text":"MPEP § 2001.06(a)","target_anchor":"d0e195900"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195888","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_a7zyesxe","edge_type":"cross-references","source_id":"pb_iegaczlf","target_id":"se_4mzlcy7f","properties":{"link_text":"MPEP § 2001.06(b)","target_anchor":"d0e195923"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195888","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_saum4wej","edge_type":"cross-references","source_id":"pb_iegaczlf","target_id":"se_jeakewet","properties":{"link_text":"MPEP § 2001.06(c)","target_anchor":"d0e195990"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195888","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_teoofhqr","edge_type":"cross-references","source_id":"pb_iegaczlf","target_id":"se_dw4peeun","properties":{"link_text":"MPEP § 2001.06(e)","target_anchor":"d0e196020"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195888","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_p2x4qgef","edge_type":"cites-statute","source_id":"pb_necvee6x","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":50,"end":61}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195904","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_o5mzbkqn","edge_type":"cites-statute","source_id":"pb_3bejxofa","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":27,"end":38}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195935","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_difiypmf","edge_type":"cross-references","source_id":"pb_n2thwjwr","target_id":"se_gokqjggw","properties":{"link_text":"MPEP § 2004","target_anchor":"d0e196215"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195948","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_x6f2raza","edge_type":"cites-statute","source_id":"pb_tpvgz6f3","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":40,"end":51}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195954","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_l325v5tc","edge_type":"cross-references","source_id":"pb_bli7rsgm","target_id":"se_ql6l6rdc","properties":{"link_text":"MPEP § 609","target_anchor":"d0e52594"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195973","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_hagxwbc4","edge_type":"cross-references","source_id":"pb_bli7rsgm","target_id":"se_nqrayyqh","properties":{"link_text":"MPEP § 719.05","target_anchor":"d0e94319"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195973","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_fxbdihdg","edge_type":"cites-statute","source_id":"pb_rrgoy4mp","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":956,"end":967}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e196000","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_hyhyjnzl","edge_type":"cross-references","source_id":"pb_kj6y7dzb","target_id":"se_ftjp5bvc","properties":{"link_text":"MPEP § 1442.04","target_anchor":"d0e141089"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e196009","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_qybzof6u","edge_type":"cites-statute","source_id":"pb_glhty7ys","target_id":"st_ktpxrf7g","properties":{"citation_text":"37 CFR 41.202(a)","specificity":"subsection","source_offset":{"start":63,"end":79}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e196028","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_tpends3f","edge_type":"cites-statute","source_id":"pb_glhty7ys","target_id":"st_ktpxrf7g","properties":{"citation_text":"37 CFR 41.202(a)","specificity":"subsection","source_offset":{"start":247,"end":263}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e196028","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_6g37hxjd","edge_type":"cites-statute","source_id":"pb_glhty7ys","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":328,"end":339}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e196028","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_eqrhslql","edge_type":"cross-references","source_id":"pb_3hhbvhrz","target_id":"se_szisyzcx","properties":{"link_text":"MPEP § 2164.05","target_anchor":"d0e215797"},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_337d9_22f81_de","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_mpbqqaex","edge_type":"cites-statute","source_id":"pb_peghdvd3","target_id":"st_pakwvrk3","properties":{"citation_text":"37 CFR 1.56","specificity":"section","source_offset":{"start":573,"end":584}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_1960f_ee","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_oa25ywja","edge_type":"cites-statute","source_id":"pb_peghdvd3","target_id":"st_jts3jwo2","properties":{"citation_text":"37 CFR 1.555","specificity":"section","source_offset":{"start":586,"end":591}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_1960f_ee","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_cghmdfz3","edge_type":"cites-statute","source_id":"pb_peghdvd3","target_id":"st_oevyffmr","properties":{"citation_text":"37 CFR 11.18(b)(2)","specificity":"paragraph","source_offset":{"start":597,"end":608}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_1960f_ee","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_plbia3jj","edge_type":"cites-statute","source_id":"pb_peghdvd3","target_id":"st_vj6qwdrc","properties":{"citation_text":"37 CFR 11.18(c)","specificity":"subsection","source_offset":{"start":827,"end":842}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_1960f_ee","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_4mcyl4pv","edge_type":"cites-statute","source_id":"pb_peghdvd3","target_id":"st_tvsspi4a","properties":{"citation_text":"37 CFR 11.18","specificity":"section","source_offset":{"start":1348,"end":1360}},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_1960f_ee","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_5tmf5bsm","edge_type":"cross-references","source_id":"pb_peghdvd3","target_id":"se_vj6nqkne","properties":{"link_text":"MPEP § 2015","target_anchor":"ch2000_d22347_2a6eb_38b"},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_1960f_ee","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_ispsbxg7","edge_type":"cites-case","source_id":"pb_mawk3sgk","target_id":"cs_vh55y3vp","properties":{"citation_text":"Brasseler, U.S.A. I, L.P. v. Stryker Sales Corp., 267 F.3d 1370, 1383, 60 USPQ2d 1482, 1490 (Fed. Cir. 2001)","source_offset":{"start":254,"end":301},"pincite":"1383","signal":"see"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195869","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_eegsiuht","edge_type":"cites-case","source_id":"pb_necvee6x","target_id":"cs_uofq6bse","properties":{"citation_text":"Gemveto Jewelry Co. v. Lambert Bros., Inc., 542 F. Supp. 933, 216 USPQ 976 (S.D.N.Y. 1982)","source_offset":{"start":486,"end":528},"signal":"see"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195904","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_jbd4pgsa","edge_type":"quotes-from","source_id":"nq_6qsfxz2j","target_id":"cs_uofq6bse","properties":{"quoted_text":"Foreign patent attorneys representing applicants for U.S. patents through local correspondent firms surely must be held to the same standards of conduct which apply to their American counterparts; a double standard of accountability would allow foreign attorneys and their clients to escape responsibility for fraud or inequitable conduct merely by withholding from the local correspondent information unfavorable to patentability and claiming ignorance of United States disclosure requirements.","quoted_text_sha256":"3726de1153426d7c4584cb612be8921c2493e3ea6e860e521903e24a37952784","source_offset":{"start":0,"end":495},"pincite":"943"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195919","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_6edwcqqf","edge_type":"cites-case","source_id":"pb_3bejxofa","target_id":"cs_zek5f3le","properties":{"citation_text":"Armour & Co. v. Swift & Co., 466 F.2d 767, 779, 175 USPQ 70, 79 (7th Cir. 1972)","source_offset":{"start":642,"end":669},"pincite":"779"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195935","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_ajkxxlnb","edge_type":"quotes-from","source_id":"nq_uax4hxhp","target_id":"cs_zek5f3le","properties":{"quoted_text":"[W]e think that it is unfair to the busy examiner, no matter how diligent and well informed he may be, to assume that he retains details of every pending file in his mind when he is reviewing a particular application . . . [T]he applicant has the burden of presenting the examiner with a complete and accurate record to support the allowance of letters patent.","quoted_text_sha256":"8f21e9393516ea4a9382c7470548d2f2a4d9be9c854fd3468e5af19715bcc26d","source_offset":{"start":0,"end":360}},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195944","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_mttndceh","edge_type":"cites-case","source_id":"pb_tpvgz6f3","target_id":"cs_tsdgh4lv","properties":{"citation_text":"Regeneron Pharm., Inc. v. Merus B.V., 144 F. Supp. 3d 530, 560 (S.D.N.Y. 2015)","source_offset":{"start":310,"end":346},"pincite":"560","signal":"see"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195954","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_jw5nuhjb","edge_type":"cites-case","source_id":"pb_tpvgz6f3","target_id":"cs_cvx4zb3m","properties":{"citation_text":"Dayco Prod., Inc. v. Total Containment, Inc., 329 F.3d 1358, 1365-69, 66 USPQ2d 1801, 1806-08 (Fed. Cir. 2003)","source_offset":{"start":394,"end":433},"pincite":"1365-69"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195954","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_c2d5vb62","edge_type":"cites-case","source_id":"pb_tpvgz6f3","target_id":"cs_cvx4zb3m","properties":{"citation_text":"Dayco Prod., Inc. v. Total Containment, Inc., 329 F.3d 1358, 1369, 66 USPQ2d 1801, 1808 (Fed. Cir. 2003)","source_offset":{"start":979,"end":991},"pincite":"1369"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195954","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_4quom62j","edge_type":"cites-case","source_id":"pb_yziethnb","target_id":"cs_u2l34bbj","properties":{"citation_text":"Environ Prods., Inc. v. Total Containment, Inc., 43 USPQ2d 1288, 1291 (E.D. Pa. 1997)","source_offset":{"start":1417,"end":1464},"pincite":"1291"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195994","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_g3o7x37k","edge_type":"cites-case","source_id":"pb_rrgoy4mp","target_id":"cs_53zck3at","properties":{"citation_text":"Critikon, Inc. v. Becton Dickinson Vascular Access, Inc., 120 F.3d 1253, 1258-59, 43 USPQ2d 1666, 1670-71 (Fed. Cir. 1997)","source_offset":{"start":1068,"end":1124},"pincite":"1258-59","parenthetical":"patent held unenforceable due to inequitable conduct based on patentee's failure to disclose a relevant reference and for failing to disclose ongoing litigation","signal":"see"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e196000","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_6u45rs4v","edge_type":"cites-case","source_id":"pb_3hhbvhrz","target_id":"cs_murlb6zx","properties":{"citation_text":"Belcher Pharmaceuticals, LLC v. Hospira, Inc., 11 F.4th 1345, 1353-54, 2021 USPQ2d 909 (Fed. Cir. 2021)","source_offset":{"start":578,"end":623},"pincite":"1353-54"},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_337d9_22f81_de","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_7ahmmnwp","edge_type":"cites-case","source_id":"pb_peghdvd3","target_id":"cs_rr6aj5aq","properties":{"citation_text":"In re Hao, Proceeding No. D2021-14 (USPTO Apr. 27, 2022)","source_offset":{"start":1223,"end":1232},"parenthetical":"involving disciplinary sanctions predicated on non-compliance with 37 CFR 11.18","signal":"see"},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_1960f_ee","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_phahm7xw","edge_type":"cites-case","source_id":"pb_42ureqy5","target_id":"cs_hjvwc6cb","properties":{"citation_text":"In re Tendler, Proceeding No. D2013-17 (USPTO Jan. 1, 2014)","source_offset":{"start":258,"end":271},"parenthetical":"suspending a practitioner for four years for failure to correct the written record after learning of inaccuracies in a declaration the practitioner had filed","signal":"see"},"provenance":{"source_file":"s2001.html","source_anchor":"ch2000_p_35e1d_18c9a_fe","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}},{"id":"e_xegh3suq","edge_type":"cites-case","source_id":"pb_vvpsvooy","target_id":"cs_2fxxg5no","properties":{"citation_text":"Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc., 326 F.3d 1226, 1234, 66 USPQ2d 1481, 1486 (Fed. Cir. 2003)","source_offset":{"start":753,"end":806},"pincite":"1234","parenthetical":"finding article which was not prior art to be material to enablement issue"},"provenance":{"source_file":"s2001.html","source_anchor":"d0e195657","source_sha256":"c3a11cdbf5bb0225f99a8fb2885f1d4c3608a00f34c3e8040e1b0492e66e9ceb"}}]}}